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Abstract 
Yeast extract, or other varieties of yeast hydrolysate, have been used in combination with a lipid 
supplement to completely eliminate the need for fetal bovine serum during in vitro cultivations of insect 
cells. This has made the process cheaper and much more attractive for large industrial uses due to the 
higher availability of yeast extract over serum. While yeast extract represents a vital step forward in 
culture media, the gold standard of a chemically defined media with the same growth parameters has not 
been achieved. To better understand the hydrolysate composition, it was subjected to trace mineral 
analysis via ICP-OES while H-NMR was used to quantify the detectable organic compounds before, during, 
and after acid hydrolysis.  
Trace mineral analysis showed that yeast extract was the sole provider of silicon, chromium, nickel and 
vanadium, as well as a majority provider of zinc, manganese, copper, cobalt and iron. While silicon has no 
known function in metabolism, the other elements are of considerable interest complicated by their 
contributions to detrimental free radical reactions. Yeast extract also provides antioxidants to help 
combat some of these reactions while possibly assisting in the trace metal dissolution due to the presence 
of several organic molecules which function as chelators. 
Through the hydrolysis studies, the yeast extract was shown to be composed of peptides heavily consisting 
of glycine, lysine and proline. Yeast extract also contains a significant amount of nucleic material, mostly 
from RNA due to the presence of uridine. Further, several B-vitamins were quantified, including significant 
amounts of B3 and myo-inositol, each more than 10x their current respective defined supplementation. 
Metabolic studies of Spodoptera frugiperda Sf-9 cell cultures in media containing hydrolysates helped to 
illuminate which compounds are active metabolites over the initial growth phase as well as determining 
any compounds which become completely exhausted. However, consistent cell growth after the 
commercial media was diluted sufficiently over 3 passages was only obtained with one of the yeast extract 
lots studied, possibly highlighting deeper concerns with the manufacturing process overall. 
Along with a thorough literature review, all of this data was combined into a chemically defined 
supplement to replace the yeast extract. No significant growth was obtained once the commercial media 
had been diluted from the system over several passages. This suggests that only a small amount of the 
crucial growth promoting compound is required, but more rigorous investigations (e.g. GC-MS, 
fractionation analysis) are still required to pinpoint its identity. 
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 Hydrolysates, such as yeast extract, are known to be highly variable in composition. While the 
relative amounts of free amino acids and most other compounds were similar in a yeast 
extract lot analysis, some instances of extreme variability were noted, including a doubling of 
trehalose content and different detected minerals, which could explain their significantly 
different effects on cell growth. 
 As expected, yeast hydrolysates of different origins have different compositions. This 
highlights the need for either strict industry process control parameters or the much more 
achievable goal of a completely defined media to completely eliminate the variable 
hydrolysate supplementation. 
 From various analytical methods, several trace metals, vitamins and other possibly 
biologically active molecules were identified as solely being provided by the yeast extract. A 
literature review identified several others highly likely to be present or other more readily 
available components with similar effects. 
 This data was combined into a fully chemically defined media supplement to replace the yeast 
extract but no significant growth was obtained, suggesting more rigorous investigation 






During the early days of in vitro cell culture, significant growth for many cell lines was only obtained 
through the use of a mammalian blood serum (normally fetal bovine). It provides functional proteins, 
amino acids, lipids, sugars, salts and trace metals for various metabolic purposes, as well as having several 
general stabilizing aspects allowing the cells to better grow in vitro1. However, it is known to be highly 
variable between lots, prone to high cost and low availability, as well as potentially containing 
contaminants or other unwanted components which could pose a problem immediately or in later 
downstream purification processes1, 2. This was a major driving force behind producing chemically defined 
media for a variety of cell lines with immediate therapeutic potential. It was not until recent advances in 
developing baculovirus expression vector systems (BEVS) as a biomanufacturing platform for a variety of 
therapeutics in insect cell lines97 that there has been a need for a high performing chemically defined 
medium (CDM). There are currently nine approved applications for using BEVS to create these 
therapeutics, most commonly in Lepidopteran cell lines98, as detailed in Table 1.1 (modified from 
Felberbaum99). Although the current production systems do not use FBS, they use other complex 
additives, meaning there is still some inherent variability between different lots of media. Improving the 
media to ensure only the required components are present will allow for the best understanding of the 
exact metabolic processes involved, will have highly reproducible results, and should be easier to seek 
regulatory approval2.  
Table 1.1: Current approved uses of BEVS. VLP: Virus like particle 
Vaccine Name Manufacturer Treatment Product Form 
Porcine    
PorcilisTM Pesti MSD Animal Health 
Classical Swine Fever Subunit 
BAYOVAC CSF E2TM / 
AdvasureTM 
 
Bayer AG / Pfizer Animal Health 
CircumventTM PCV Merck Animal Health 
Porcine Circovirus type 2 VLP Ingelvac CircoFLEXTM Boehringer Ingelheim Vetmedica 
PorcilisTM PCV MSD Animal Health 
 
Human 
   
CervarixTM GlaxoSmithKline Human Papillomavirus VLP 
FlublokTM Protein Sciences Corporation Influenza subunit 
ProvengeTM Dendreon Prostate Cancer immunotherapy 





Since the development of IPL-41 by Weiss et al.3, industrial scale serum-free culturing has been 
shown possible by supplementing yeast extract and a lipid emulsion to a chemically defined basal medium 
consisting of amino acids, sugars, salts, vitamins and trace metals. Yeast extract, also referred to as 
yeastolate or yeast hydrolysate, is the water soluble portion of autolyzed yeast biomass (normally 
Saccharomyces cerevisiae [i.e. Brewer’s yeast] due to its abundance but any other species could be used)  
primarily containing amino acids and peptides, but also a source of B-vitamins, sugars, salts, and trace 
metals. The hydrolysate contains most of the components provided by serum, while the lipid solution 
provides others, but a majority of the larger compounds in the serum can be excluded without detrimental 
effects (as attested from the performance of the commercial media). Although most serum-free media 
use yeast extract, other hydrolysates (e.g. meat, egg, milk, soy4-8) have also shown positive effects in 
culture, but the results are normally dependent on the cell line and the optimum type and level of useful 
hydrolysates must undergo extensive investigation1. Even once suitable hydrolysate levels are found, 
screening methods are normally required to ensure that the hydrolysate lots pass some base criteria 
before being deemed appropriate for full scale use9, 10. Therefore, while hydrolysates represent an 
important step forward in insect cell culture research, only very recently has there been a reported CDM 
for Sf9 insect cells (i.e. SpodOmicsTM, Cell Culture Technologies) but it still does not perform as well as 
those containing hydrolysates (e.g. Sf-900 IIITM, Gibco), meaning improvements can still be made to 
completely eliminate any potential for batch-to-batch variability. 
By analyzing yeast hydrolysate, insights on the specific quantities of certain components could 
help to open up new windows of investigation to create this elusive CDM. 
1.1 Hypothesis 
While a CDM is available for insect cells, it still does not perform as well as those containing hydrolysate 
supplements. It is hypothesized that a thorough characterization of yeast extract by H-NMR spectroscopy 
and trace metal analysis will provide the required information to derive a chemically defined replacement 
for yeast extract and other hydrolysates. 
1.2 Objectives 
To most efficiently analyze the yeast extract, trace metal analysis and hydrolysis techniques will be 




Acid hydrolysis has long been a favoured technique to determine amino acid sequence of peptide 
chains14. The extreme conditions allow for the complete hydrolysis of peptide bonds but has several side 
effects: the complete destruction of tryptophan (Try) and cystine (Cys); the slight destructions of serine 
(Ser) and methionine (Met); the conversions of glutamine (Gln), and asparagine (Asn) to glutamate (Glu), 
and aspartate (Asp), respectively; and the conversion of sugars to levulinic acid, formic acid, and several 
by-products31. Since about half of the nitrogen in the yeast extract is in peptide form16, and it contains a 
variety of other organic bonds (e.g. phosphate, ester, or glycosidic), this will allow for a significant amount 
of new material to be quantified. 
H-NMR spectroscopy allows a wide variety of molecules to be detected in a single spectrum, which 
can then be easily interpreted through available software packages. While a wide range of components 
are detected at once, there are still some components that could be in yeast extract that are undetectable 
to some scan parameters because they have an inappropriate hydrogen ion (e.g. guanidine and uric acid). 
Although this methodology will be unable to account for all the contributions in one hydrolysate, it 
provides extensive information which would otherwise require significantly more resources. However, as 
this is a study on H-NMR spectroscopy and its applicability to complex organic solutions it is accepted that 
some components may not be identified. The success of using NMR in this manner can be concluded 
based on the percentage of the original material that is quantified.     
Yeast extracts are known to be heavily variable in trace metal composition22, 23, which can be 
involved in free radical reactions that harm other biological molecules27. A chemically defined medium 
will require carefully controlled levels of these compounds to be as effective as possible. Inductively-
coupled plasma optical emission spectroscopy (ICP-OES) will be used to measure the quantity of twenty 
different cations present in yeast extract, as well as the overall level in a variety of media. 
All of this information will be utilized to compare the growth of Spodoptera frugiperda Sf-9 clone 
cells in commercial media with hydrolysates to an in-house media with and without hydrolysates. Growth 
profiles will be maintained for each culture as they are adapted to the new media, and cultures exhibiting 
consistency in reaching at least 6x106 cells/mL in less than 10 days were subjected to metabolic analysis. 
1.3 Anticipated Contributions and Impact of Analysis 
This thesis will hopefully provide several insights on various methodologies and phenomena 




 Thorough statistical analysis using H-NMR spectra to quantify the semi-defined product of yeast 
extract and to test the variability of the analytical process as it compares to the variability 
between different lots and suppliers. 
 Novel acid hydrolysis methodology and modelling of yeast extract to determine if this provided 
new areas of interest when creating a chemically defined medium for insect cells. 
 Understanding and comparing the metabolism of a cell line due to different complex additives 





2.0 Insect Cell Media and Metabolism 
2.1 Historical Evolution of Insect Cell Lines and Media 
The basis of all media is the same: an aqueous mixture of carbohydrates, amino acids and salts with a 
suitable buffer. However, the quantities of these components is heavily dependent on the family, species 
and even specific cell lines1.  
 Although hundreds of cell lines from various species and orders have been isolated100, the 
Lepidopteran species Spodoptera frugiperda produced two of the most popular industrial cell lines: Sf-21 
and Sf-9 clones99. Sf-21 cells were established from isolated ovarian cells by Vaughn et al.101 This cell line 
was then developed into Sf-9 cells by Smith and his group99, 102. These cell lines have become popular since 
they are highly susceptible to infection by Autographa californica multiple nucleopolyhedrosis virus 
(AcMNPV) or other baculoviruses, creating a rigorous biomanufacturing platform called insect cell BEVS 
(IC-BEVS). With the complete DNA sequence and individual gene functions of the AcMNPV highly 
studied103, a number of different promoters have been analyzed to assess their performance for protein 
production. Usually, the gene for the production of polyhedrin (proteins used to protect the virus in the 
natural environment and are therefore unnecessary in cell culture) is replaced with the protein of interest 
due to it being controlled by a very strong promotor and thus results in high protein yields99.  The infection 
cycle will generally start expressing this product 18 hours post infection (h.p.i), but it is overexpressed 48 
to 120 h.p.i.104, after which the cytopathic effects from infection result in cell lysis and the release of the 
product into the supernatant. While there are many benefits for IC-BEVS, the two most important are: 
their inherently safe nature since they are unable to infect native mammalian cells105 (and the modified 
baculovirus is unlikely to survive in nature without the polyhedrin); and they are able to express genes 
from eukaryotic, prokaryotic and even viral organisms106, 107. 
Initial media for Lepidopteran cells came from analyzing hemolymph. Grace’s35, TNM-FH36, and 
TC-10037 were all initial attempts at media for in vitro insect cell culture and contain carbohydrates, amino 
acids, organic acids, and vitamin mixtures supplemented with 5-10% fetal bovine serum (FBS). FBS is a 
complex, protein-containing supplement providing detoxifying effects, carrier molecules, and protection 
from shear stress1. However, FBS in non-ideal for several reasons: high cost and low availability; batch-to 
batch variability; and possible contaminants or unwanted compounds1. Further, since the FBS is protein-
rich, this adds complications when the trying to prepare a purified protein product made through 




but due to the issues surrounding its use many groups attempted to replace it with less variable and more 
defined supplements.  
Several possible serum substitutes have been investigated, including peptones (hydrolyzed animal 
tissues), egg yolk emulsions, and lactalbumin (milk proteins) 4-6, 79. However the greatest effect is achieved 
with yeast extract or yeastolate, products of autolyzed yeast biomass1, 79. Supplemented in conjunction 
with a lipid emulsion, yeast extract is able to provide excellent growth for Lepidopteran lines1, 79. 
Yeastolate is known to be a heavy provider of vitamins, trace metals, and bioactive peptides known to 
stimulate either cell growth or viral protein production15. Yeast extract is also beneficial as it is a non-
animal derived source, increasing the safety and reproducibility of the product (although there is still some 
batch-to-batch variability in yeast, it can be minimized through ultrafiltration79). Nowadays, several 
serum-free commercial media are available but due to their proprietary nature, the exact formulations 
are unknown (and thus could be animal-derived if not otherwise acknowledged), but in any case, contain 
some sort of hydrolysate. Commercial media is generally restricted to a specific cell line or a narrow range 
of similar lines when claiming growth parameters. This means that while cells could stay viable in a non-
specific media, their growth will most likely be heavily affected away from optimum values. 
2.2 Culturing Parameters 
Culture parameters, such as temperature, pH, osmolality, dissolved gases, and shear stresses, heavily 
influence the growth of cells. Insect cells obtain a maximum growth rate and cell density at a temperature 
of 27 0C38, but are tolerant between 25 and 30 0C. Higher temperatures can reduce overall protein yield in 
Sf-9 cells39. A medium pH between 6.0 and 6.8 is acceptable, requiring only a phosphate buffer (as 
opposed to a pH of 7.4 and the CO2/bicarbonate system required for mammalian systems). Sf-9 cells 
prefer a medium between 6.2 and 6.440. Insect cells can also tolerate media with an osmolality anywhere 
from 250-450 mOsm/kg, but is generally kept between 320 and 385 mOsm/kg41. Dissolved oxygen is an 
important factor during both growth and infection stages, with oxygen uptake rates increasing during 
infection42. However, more dissolved oxygen results in increased CO2, which is known to inhibit growth 
and protein production beyond 24 mM, possibly due to intracellular pH changes43-45. Suspension cultures 
require some sort of agitation to maintain their suspension nature as well as to ensure proper oxygen 
transfer rates but cannot withstand the force generated by a classic stirred tank or bubble column46, so 
careful engineering is required to keep these forces to a minimum for large scale designs. For small scale 




is preferred47-48. A non-ionic polyol surfactant (such as Pluronic® F-68[Gibco©]) is added to help control 
shear forces as well as minimize any surface adhesion. 
2.3 Media Component Groups 
Altogether, insect cell media can contain 75-100 individual components, making the development of an 
optimal medium a tedious process. Compounds can be grouped into the following major categories: 
 Bulk Ions (or Osmolites) [ Na+, K+, Ca2+, Mg2+, Cl-, SO42-] 
o While not explicit metabolites, Na+ and K+ are directly coupled to ATPase pumps, which 
provide secondary potential to transport larger molecules into the cell, while Ca2+ and 
Mg2+ are essential components of many enzymes.  
 Sugars and Organic Acids  
o While cultures can grow solely in the presence of glucose, some disaccharides can be 
externally degraded in the supernatant by excreted amylases. This could allow for lower 
levels of glucose while lowering the accumulation of by-products that occur under glucose 
excess. While some organic acids are used as carbon sources, this is heavily dependent 
on the media and the other metabolites it provides50. 
 Amino Acids 
o The amino acids have many interacting effects50. As such, understanding optimal 
supplementation requires detailed experimental design. It is also highly likely that this will 
be heavily affected by the protein production phase (i.e. there should be more than 
enough amino acids for both stages of the culture). 
 Lipids [fatty acids, sterols] 
o Being the main constituents of cell walls, these compounds should have a heavy influence 
on growth rate. Since only a maximum of 20% of glucose is converted into lipids52, 53, lipid 
supplementation would allow the cell to have an initial pool of these metabolites without 
having to wait for the full conversion process from glucose. 
 Vitamins and Trace Metals 
o These compounds are important co-factors for several enzymes and other metabolic 
processes. Although only present in small amounts, these compounds are crucial for 
growth but are probably heavily involved in determining oxidative stress (the term for the 




 Antioxidants [e.g. ascorbate, glutathione, Vitamin E] 
o Due to the dissolved oxygen and aerobic conditions, the media is an actively oxidative 
environment, able to damage macromolecules through perpetuating free radical 
reactions27. Further, cultures can become much more oxidative during viral infection 
stages81. Therefore supplementation of antioxidants help to eliminate some of these 
radicals and create a more conducive environment for growth. 
 Micronutrients 
o These are classified as biologically active compounds wherein their supplementation has 
not ever, or fully been, investigated in insect cell culture. These compounds include 
polyamines (e.g. cadaverine), phospholipid head groups (e.g. ethanolamine), and other 
lipid related compounds (e.g. carnitine).  
2.4 Insect Metabolism in Suspension Culture 
Understanding the metabolism of cells is important to ensure sufficient quantities of substrates are 
available in the media to sustain prolonged growth.  
2.4.1 Carbohydrates 
Glucose is the preferred carbon-source for insect cells and is consumed at a much higher rate than in 
mammalian cells21. Other carbon sources (e.g. fructose and lactate), can be utilized after glucose has been 
depleted from the media50, 51. Supernatant from Sf-9 cultures actively digests maltose and trehalose into 
glucose, suggesting the presence of secreted amylases (data forthcoming). Insect cells regulate their fluxes 
such that 80% of the pyruvate formed from glycolysis eventually feeds into the TCA cycle, leaving the 
remainder for lipid and alanine production52, 53. While glucose is required for growth, cells are able to 
remain viable in the media if sufficient amino acids are available but excess glucose can lead to the 
accumulation of lactate and alanine50, 54, reducing the efficiency with which other active metabolites are 
produced. While TCA intermediates can be used as a carbon source, they are not consumed during the 
growth phase6, and their absence does not affect growth37.  
2.4.2 Amino Acids 
Gln is the main amino acid used as an energy source for Sf lines54 possibly through conversion into α-
ketoglutarate (AKG) through Glu, but while Sf-9 cells possess a Gln synthase54 (to create Gln from Glu), its 




energy sources for Sf-9 cells are arginine (Arg), Asn, Asp, Met, and Ser49. The majority of amino acids are 
not synthesized by the cell57, necessitating their supplementation. Isoleucine (Ile), lysine (Lys), histidine 
(His), leucine (Leu), Met, and threonine (Thr) are all crucial for Sf-9 growth and delaying cell death55. The 
amino acids Arg, Asn, Asp, Gln, Glu, glycine (Gly), and Ser are required to sustain high growth of Sf-9 cells58 
as well as being necessary during infection phases to obtain high protein production31.  
2.4.3 By-products of metabolism 
The most significant by-product that accumulates over the course of an Sf-9 culture is alanine (Ala). When 
Asx is converted to oxaloacetate, or Glx is converted to AKG, pyruvate acts as an ammonium sink to 
produce Ala56. While ammonium toxicity is not fully studied in insect cells99, its effect is probably similar 
to that of mammalian cells: the acidification of the cytoplasm and mitochondria coupled with competition 
of ammonium and K+ through ATPase transport pumps60, 61. Insect cultures are generally more tolerant 
than mammalian cultures to ammonium content50, 61, and can tolerate up to 100mM of Ala28.  
2.4.4 Lipids 
It is known that insect cells have an incomplete lipid metabolism, leaving them unable to synthesize, 
desaturate and elongate fatty acids as well as being unable to anabolize cholesterol57. Supplementation 
of long chain, unsaturated fatty acids (i.e. oleic, linoleic, and linolenic acids) improve growth of insect 
cultures significantly, and these fatty acids are used directly to create more cellular membranes62.  
2.5 Yeast Hydrolysates 
2.5.1 Production of Hydrolysates 
There are two main methods for the production of hydrolysates. Either biomass can be exposed to 
enzymatic hydrolysis (through the initiation of autolysis or the addition of external proteases11-14, 16), or 
through acidic or alkaline hydrolysis12, 14. The latter process occurs in extremely alkaline or acidic 
conditions and at relatively high temperatures (e.g. HCl digestion occurs at 6M acid and 1200C). These 
extreme conditions completely hydrolyze all organic bonds at various rates but results in a product of 
relatively high salt content. Enzymatic digestion, on the other hand, occurs at relatively moderate 
conditions (autolysis at about 600C11 or proteases at 370C13, 14) allowing the final overall salt concentration 
to remain low. Further, these more moderate conditions also preserve several components lost through 




the final product is a mix of free amino acids and relatively short oligopeptide chains. Experiments have 
shown the most positive results are obtained using the fraction of yeast extract less than 3kD in size15, 79, 
indicating that the short chain oligopeptides and free components are the most important. 
To produce yeast hydrolysate through autolysis, a high density culture of yeast cells is exposed to 
either a heat or osmotic shock to kill the cells without inactivating the autolytic enzymes. The autolysis is 
then allowed to continue for up to 60 hours. The slurry is then filtered and centrifuged to remove insoluble 
and lipid components. The final product can then either be concentrated into a slurry or spray-dried into 
a powder16, 17. From this simplified process, it becomes clear why hydrolysates can vary so widely. Not 
only will the specific strain and their growth conditions provide some inherent differences, but the length 
and method of hydrolysis as well as any downstream processing will be important18-20. However, even 
with all of these potential differences, differing lots produced years apart can have similar effects on a cell 
culture. This means the most important compounds are not affected, again indicating that the most 
necessary compounds are probably small individual components as opposed to a long specific 
oligopeptide sequence (the experiments by Chou et al.15 show that growth is detrimentally affected when 
compounds <1kD are excluded). One study80 identified four unique peptide strands (heavily composed of 
Pro and Lys) from yeast specific protein sequences in 8 different lots of yeast extract, attesting to the 
continuity of the product over time. 
2.5.2 Composition of yeast extract 
As initially stated, yeast extract is composed of amino acids, short polypeptides, carbohydrates, salts, trace 
metals, and vitamins. As most of these components are easily measureable with relatively simple tests 
(e.g. liquid chromatography (LC) for amino acids and carbohydrates, inductively couple plasma optical 
emission spectroscopy (ICP EOS) for trace metals and salts, the Kjeldahl method for total nitrogen), crude 
compositions are readily available. However, there are very few comprehensive studies of yeast extract 
available and several techniques, including surface-enhanced Ramen scattering93 and fractionation 
followed by high performance LC87, 92 have been useful to screen lots or analyze for a specific chemical, as 
opposed to complete characterization. This is further complicated by the high variability between lots and 
suppliers of yeast extract which makes extrapolating components and even concentrations between lots 
highly risky22, 87, 88, 90.  Therefore, while other papers have been cited appropriately, they would be hard to 
directly compare to any analysis performed in this work. However, BD Biosciences supplies technical 




different lot but the same product), and provides the best point of comparison to check this study’s result. 
Table 2.1 provides a crude breakdown of the yeast extract lot, as analyzed by BD Biosciences.  


















10.7 6.0 0.56 14.3 11.7 2.2 
 
Although this crude breakdown does not help to identify the actual beneficial components, it does 
provide the first hints into the overall content of yeast extract. Firstly, the degree of hydrolysis shows that 
over half of the nitrogen is free amino acids; the other nitrogen would be mostly in the oligopeptides, but 
also in any vitamins and nucleic material. The total carbohydrates (based on a sulfuric acid-phenol 
colorimetric assay) represent the common sugars (glucose and fructose) and their polymers as well as any 
(deoxy)ribose due to nucleic material. Ash can be taken as a general measurement of the total inorganic 
ions present (sodium and potassium account for most of the weight).  
Further refinement on the composition can be achieved with more rigorous analysis. For the BD 
yeast extract summarized in Table 2.2, this included: 20 hour acid digestion for total amino acid levels; ion 
chromatography for chloride, sulphate and phosphate anions; ICP OES for elemental cations. Table 2.3 
compares the levels in the IPL-41 chemically defined basal media to supplementation at 4 g/L. 
Table 2.2: More detailed analysis of yeast extract components (modified from BD Biosciences16) before and after 
acid hydrolysis. Components with an asterisk are completely or partially destroyed, as noted by BD. 











Alanine 4.6 4.6 Leucine 3.5 4.9 Calcium 228 
Arginine 1.7 2.4 Lysine 2.3 4.2 Iron 73.7 
Asparagine* 1.2 -- Methionine* 0.8 0.8 Magnesium 250 
Aspartic Acid 1.8 4.8 Phenylalanine 2.3 3.3   
Cystine* 0.2 -- Proline 0.9 1.8 Other Ions (w%) 
Glutamic Acid 6.6 8.7 Serine* 1.5 1.4 Potassium 5.09 
Glutamine* 0.3 -- Threonine 1.3 1.4 Sodium 0.82 
Glycine 1.3 2.7 Tryptophan* 0.6 -- Chloride 0.3 
Histidine 0.5 1.1 Tyrosine 0.8 0.9 Sulfate 0.49 
Isoleucine 2.1 3.6 Valine 2.4 3.7 Phosphate 2.63 













Table 2.3: Comparison of concentration from yeast extract and chemically supplied in IPL-41 basal medium. Iron is 
highlighted as it is the only compound supplied more by the yeast extract than the basal medium 

















Alanine 0.18 0.00 Leucine 0.20 0.25 Calcium 0.9 181 
Arginine 0.10 0.66 Lysine 0.17 0.56 Iron 0.29 0.11 
Asparagine* 0.05 1.30 Methionine* 0.03 1.00 Magnesium 1.0 185 
Aspartic Acid 0.19 1.30 Phenylalanine 0.13 1.00 Potassium 204 629 
Cystine* 0.01 0.10 Proline 0.07 0.50 Sodium 33 1361 
Glutamic Acid 0.35 1.50 Serine* 0.06 0.40 Chloride 12 3454 
Glutamine* 0.01 1.00 Threonine 0.06 0.20 Sulfate 20 732 
Glycine 0.11 0.20 Tryptophan* 0.02 0.10 Phosphate 105 799 
Histidine 0.04 0.20 Tyrosine 0.04 0.25    
Isoleucine 0.14 0.75 Valine 0.15 0.50    
 
 
From Table 2.3, the levels of most basal compounds are not significantly affected. However, when 
looking at the iron levels, IPL-41 supplements 110 µg/L (as FeSO4•7H2O) and the yeast extract could 
provide 295 µg/L. From this preliminary analysis, media without yeast extract could only have 25% of the 
iron that would normally be present. Due to the importance of iron for a variety of metabolic processes, 
removing the yeast extract without further supplementation should have serious effects. Further, other 
reports22, 23, 91 show a wider range of detected elements not added to the basal media, as well as significant 
variation between lots in some cases. Trace elements can have significant effects on cell culture both in 
metabolic roles24-26 and as general toxins which lead to the formation of peroxide molecules that initiate 
free radical reactions27. All of these factors necessitate the need to carefully control the quantities of these 
components in the media and to exclude those without a metabolic role. 
Yeast extract is also a known provider of nucleic acids and related nucleic material in both free 
nucleoside28, 29 (most likely as ribonucleotides32) and phosphorylated forms22, 28, 29. These nucleosides have 
sizes between 3 and 25 bases, while accounting for about 1% of the total weight of the yeast extract80, 
but could be as high as 10%89. Riboflavin (B2) has also been proven to be in yeast extract30, but a variety 
of B-vitamins, including niacin or nicotinate (B3), biotin (B7), pantothenic acid (B5), thiamine (B1), choline, 




2.5.3 Role of Yeast Hydrolysates 
Due to the complex nature of yeast extract, it provides compounds from all of the presented categories 
of culture media. Therefore, the explicit benefit of the yeast extract to cell culture must be from 
components not already supplied. These are likely to be some trace metals, antioxidant chemicals, and 
possibly some minor, but important, bioactive chemicals (e.g. polyamines). Some hints at the necessary 
components can be deduced from those cell lines that once required hydrolysates, but have since been 
found to grow in media with completely chemically defined elements.  
Wilkie et al68 report a CDM for lepidopteran cells. While it included several additions over the 
normal CDM basal media, many groups report it was unable to sustain any high growth of cultures without 
adding additional compounds58, 66. Mitsuhashi developed a CDM for a Sarcophaga peregrine cell line (NIH-
SaPe-4)66, 67. Compared to IPL-41, several additional compounds including nucleic, lipid, and other possibly 
biologically active components, including polyamines, are found.  
An extensive review on the development of CDM for mammalian cells was compiled by van der 
Valk63. He shows that most media need an additive known as ITS, which provides insulin, transferrin, and 
selenium. Insulin and transferrin aid in glucose and iron membrane transport, respectively, whereas 
selenium is a necessary component for several antioxidant enzymes. Glucose already has higher uptake 
rates in insect cells than mammalian cells49, so insulin is probably unnecessary for insect cells. While in 
vivo cultures of insects do use transferrin to regulate iron levels64, some insect cell lines have shown its 
(and insulin’s) supplementation does not eliminate the dependency on complex additives65. The addition 
of selenium presents the most interest due to the oxidative nature of in vitro cultures27. Since it is not 
added to a variety of basal medium, yeast extract could be the only source of this element (about 4 µg/g 
dry cell weight of yeast cultures84 and mostly as selomethionine85).  
With the knowledge gained through metabolic studies and drawing parallel conclusions to work 
performed in other eukaryotic systems, a more complete understanding of the requirements for a defined 
media will be obtained. Outside of carbohydrate and amino acids studies, other known requirements of 




3.0 Selected Methodologies 
Due to the variety of components expected to be detected in yeast extract (as well as in cell culture 
metabolism overall), identifying every component is possible through the use of multiple quantitative 
systems and extensive analysis for qualifying any unknown compounds. However, H-NMR spectroscopy 
coupled with an extensive software database (Section 3.1) allows for quick quantification for a large 
variety of compounds while providing insights on any unqualified compounds from residual spectral 
peaks. However, since yeast extract is known to contain a variety of organic bonds, these may need to be 
hydrolyzed before they can be detected by H-NMR. Acid digestion has long been a favoured practice to 
hydrolyze organic bonds, but due to the intense nature of the reaction, several considerations must be 
made (Section 3.2). 
3.1 NMR spectroscopy 
Nuclear Magnetic Resonance (NMR) spectroscopy is an established technique to quantify a large selection 
of components found in a variety of biological fluids69. Briefly, a liquid sample is subjected to a strong 
magnetic field which magnetically aligns all components in the sample. Relaxing this magnetic field causes 
the molecules to re-align themselves to their biologically native state. The machine is then able to 
interpret this re-alignment and produce an appropriate spectrum to qualify or quantify components of 
interest. 
Historically, carbon-13 NMR (13C-NMR) was the established method to quantify components for 
use in intracellular flux analysis. However, it is relatively expensive due to the necessity of 13C-labelled 
components as well as being heavily influenced from the complex interpretation of the spectra. 
Conversely, the use of proton NMR (or H-NMR) is a much simpler process in terms of sample preparation 
and data acquisition. Although it was initially used in order to determine the purity of pharmaceuticals, it 
has recently shown to be useful for the quantification of a wide range of metabolites in a variety of 
biological fluids, including media monitoring during cell culture and recombinant protein production75.  
The fundamental underlying principle of any NMR is that the intensity of the signal is linearly 
proportional to the number of nuclei responsible for that signal. These two parameters (signal intensity 
and number of nuclei present) can be equated by developing a constant specific to the spectroscopy unit 
dependent on many properties of the actual scan (Bharti and Roy69 compiled an excellent review of all the 




all parameters specific to the scan). These spectroscopy parameters can be accounted for by calibrating a 
known standard. This can include an internal calibration (a known quantity of a compound is added 
directly to the sample), external calibration (a known quantity of a component is scanned in a co-axial 
tube), or electronic calibration (a synthetic signal generated by the NMR). Metabolite concentrations can 
then be determined by comparing this standard and its intensity to that of the other compounds. This 
means that any error when generating the standard peak will be present in all subsequent quantities. One 
of the largest sources of error comes from improper phase and baseline corrections, a mostly user 
subjective process70-72.  
As implied, H-NMR measures protons, and therefore different functional groups possessing a 
hydrogen atom are able to be qualified through NMR since they will result in different signal patterns (i.e. 
a methyl group [-CH3] will have a much different spin than an ethylene group [-CH=CH-]). These signals 
are also influenced by neighbouring functional groups and how they interact with protons (i.e. nearby, 
heavily polar functional groups can distort ideal readings). When performing aqueous H-NMR scans, the 
main pre-processing of the required signal is to suppress the water peak. If this is not adequately 
performed, the water signal would completely dwarf any other peaks, making acquisition useless. Due to 
this suppression, any hydrogens which are able to interchange with water are masked (i.e. uric acid). 
Further, compounds possessing peaks near water also suffer from inadequate water suppression issues.  
As alluded to, proper preprocessing and calibration is required before the NMR spectra can 
produce any meaningful results. Three of these most important steps are: matching and tuning; water 
suppression; and shimming69. Matching and tuning are important to ensure the 900 pulse (i.e. the intense 
magnetic pulse which aligns all spins before the acquisition) is as effective as possible at exciting the 
molecular spins. Shimming helps to create a homogenous magnetic field to ensure the peaks are as ideal 
as possible. Water suppression helps to eliminate the influence of the water peak and increase the 
sensitivity to minor components. These steps are initially verified by visually inspecting the magnitude of 
the water peak and the shape of the internal standard. 
The sensitivity of an NMR scan depends on a variety of factors, some of which are inherent issues 
of the NMR process. Since the NMR scan is dependent on the number of protons present, if a compound 
is at too low of a concentration, peaks can be indistinguishable from the baseline. Further, for those 
compounds present at a significantly high concentration, their peaks can completely dominate the 
spectrum and potentially convolute the appearance of the less concentrated components. This same issue 




distort the spectrum’s baseline. To complicate the issue more, the large variety of compounds present in 
yeast extract can create stearic interference, hindering the effectiveness of the magnetic field and 
subsequent acquisition. Therefore, while performing scans with higher concentrations could enable some 
peaks to be seen or become clearer, it could also create issues reading those compounds already present 
at detectable levels. To overcome this, differing concentrations of the yeast extract can be read to 
determine the effect the overall ionic strength has on the individual readings. Overall, quantification via 
H-NMR is expected to have about a 5-10% variance75. 
If the preprocessing is successful, the next step is analyzing and interpreting the resulting 
spectrum. Normalization to the area of the standard component provides the basis of quantification, 
which can then be converted into a molar concentration depending on the number of hydrogens 
represented by a specific peak. From here, there are two major methods of performing area analysis: 
binning or targeted-profiling. In binning, the spectrum is broken up into several individual sections and 
the total area in each bin is calculated and normalized. Since each peak location typically represents 
compounds with similar components, binning allows for an indirect analysis of component groupings. 
However, since many compounds have more than one readable hydrogen group, there will be multiple 
resulting peaks, meaning binning tends to increase the number of variables during analysis. Targeted 
profiling requires fitting a compound’s known peaks to those found in the spectrum. This is easily done 
with software such as Chenomx© NMR Suite©. Chenomx© contains a large library of idealized components 
peaks, allowing for specific components to be analyzed and quantified, enabling more precise results to 
be obtained from analysis. However, since the library peaks are ideal (normally acquired in deionized 
water at various pH levels to ensure maximum applicability), complex mixtures and extreme pH variations 
cause the resulting peaks to be less ideal than expected, possibly introducing some error and uncertainty. 
A comparison of binning and targeted profiling is shown in Figure 3.1. Here, both binning and targeted 
profiling can produce four data points of analysis (although all six bins would be analyzed in practice). 
Targeted analysis provides evidence that levulinate, succinate, glutamate, and valine are all present in the 
sample. Binning convolutes many compounds (bin 2 contains three separate components as this spectral 
location seems to represent –CH2– between carbonyl [C=O]) and still requires compounds to be identified. 
While binning and targeting could produce the same amount of data points, this spectrum portion is less 
convoluted than typical cell culture spectrum. For example, in the work of Weljie’s70 group, 11 compounds 
required 45 custom bin sizes, over 4 times the amount of data obtained from targeted profiling. Since 
most of these bins contain redundant information (i.e. multiple bins are for the same compound), this 





Figure 3.1: Comparison of binning and targeted-profiling techniques for a sample H-NMR spectrum. The green line 
represents the subtraction of the individual ideal peaks from the total spectral area, and here shows that there is 
very minimal residual leftover, indicating that the remaining area is most likely due to error when fitting an ideal 
profile in a less-than-ideal environment. Six possible bins of variable size are also shown for comparison. 
With targeted profiling, it is important to remember that the confidence in identifying a 
compound results from the confidence in the presence of its peaks. Therefore if the peaks are heavily 
distorted or convoluted, or the compound is simple enough to only have one peak in H-NMR, then low 
confidence should be provided to that identification unless the compound is known to be present. This 
creates the paradox when trying to qualify unknown compounds in the spectra which only have one peak, 
or are present in heavily convoluted areas of the spectrum. For example, succinate and pyruvate are both 
simple organic acids used in the TCA cycle and therefore profiling both of them in the same solution could 
be possible. However, as shown in Figure 3.2, there is a slight spectral overlap of where these compounds 
are expected. Therefore, depending on the exact pH and ionic strength of the solution, it would not be 
impossible to have both peaks in this location. Further, as the peaks represent different quantities of 
measured hydrogens, the resulting quantification would be different depending on the peak assignment 
(Figure 3.2 has both components quantified at 0.5 mM). Therefore, to use H-NMR to quantify these 
compounds, various pH ranges and ionic strengths would have to be analyzed to see if this will separate 
the compounds far enough for one of them to move into their expected range (assuming the analyzed 
solutions are still in an appropriate state for quantification via NMR). Apart from the amino acids, glucose, 
and trehalose, which have been repeatedly quantified in yeast extract, other identified components must 
be based on how confident the profiling is based on the spectrum (i.e. any new compound should have at 
least two unconvoluted peaks to be completely confident in its identification).  Those not meeting this 






Figure 3.2: Comparison of expected H-NMR peak locations for succinate (black) and pyruvate (red). Both 
compounds are profiled at 0.5 mM to highlight the difference in quantification if not properly assigned 
3.2 Acid Digestion 
Acid hydrolysis of proteins has been in practice for decades since the extreme conditions allow for the 
complete hydrolysis of peptide bonds14. However, the process results in the complete destruction of Try 
and Cys from oxidation; the slight oxidations of Ser and Met; and the conversion of Gln and Asn to Glu 
and Asp, respectively. Other compounds with amide functional groups can also be converted into their 
carboxylic counterpart (e.g. niacin is converted to nicotinate).  Further, acid digestion completely destroys 
pentoses and hexoses through several acid hydrolysis pathways31. The most prevalent reaction scheme to 
occur is the dehydration of the hexoses to 5-hydroxymethylfurfural, followed by its hydrolysis to formic 
acid and levulinic acid. A schematic of the hexose reaction is shown in Figure 3.3. A number of side 
reactions create glucose reversion products as well as insoluble black precipitate known as humins which 
must be removed or they will interfere with the NMR scan.  
 
Figure 3.3: Acid hydrolysis mechanism for the conversion of glucose to levulinic acid 
 




3.2.1 Kinetic Modelling 
Due to the intense environment required for acid digestion, it is expected that some compounds will be 
degraded, meaning their final observed concentration could be an underestimation of the total initial 
content in the yeast extract. Therefore, observing how the solution evolves over time will provide the 
most comprehensive analysis of the products liberated from the yeast extract, in terms of both actual 
quantity and any compounds that may be liberated and destroyed within the span of the hydrolysis. 
Several reaction models are expected, as summarized in the following sections. 
Amino Acids 
Kinetic modelling of peptides is difficult to accurately model since compounds are liberated from their 
chains in a random order while many undergo a slight, constant degradation. While most reports will 
simply extrapolate to a zero time to overcome such issues, Robel and Crane95 developed a novel (but 
rather simple) model to account for them directly. They assumed that the amino acids existed in one of 
three states (peptide, free, or destroyed) but that insignificant destruction of peptide bound amino acid 
occurs. Since the reaction is monitored by the amount of free amino acids, a simple material balance with 
a first order assumption on the free amino acids produces Equation 1. 
𝑟𝐹 = ℎ𝐶 − 𝑑𝐹 
Where r is the rate, C is the peptide concentration, F is the free amino acid concentration, h is the 
hydrolysis constant, and d is the destruction constant. Normalized amino acid amounts (i.e. g/g and not 
g/L) are normally used so that h and d represent a fractional conversion. In constant-volume batch reactor, 
the free amino acid concentration can be represented by Equation 2 where C0 is the initial amount of 




(𝑒−𝑑𝑡 − 𝑒−ℎ𝑡) 
As this model was just for a protein solution, Darragh and Moughan94 extended (and validated) this model 
for more complex solutions which begin with an initial amount of free amino acids. They modified the 
model by adding a second destruction term for just the initial free amino acids, as shown in Equation 3 












As short chain oligopeptides are dominant in yeast extract, it is highly unlikely that hydrolysis times of 
over 150 hours is necessary to completely hydrolyze the sample as used in the previous reports94-97 (12 
hours was the chosen hydrolysis time; see Section 4.4 for complete experimental procedure). Since the 
destruction coefficients are generally 2 or 3 orders of magnitude less than the liberation ones (even for 
complex solutions94), any destruction over this experiment will be insignificant compared to the expected 
liberation (excluding the amino acids already mentioned). Since there is very little destruction, C0 should 
be relatively close to the difference in the amino acid concentrations before and after acid digestion. The 
very little degradation may also mean that the destruction coefficient can be ignored if the observed 
reaction profiles do not warrant its inclusion (since NMR will vary by about 5-10%, the noticed decrease 
should be at least 15% to include the term). This would reduce the model to Equation 4. 
𝐹 = 𝐶𝑜(1 − 𝑒
−ℎ𝑡) + 𝐵0 
All of the above models assume closed batch kinetics. This is due to the standard practice of performing 
acid hydrolysis in specialized sealed vials meant to maintain a perfect vacuum batch reaction14. Due to 
economic and safety considerations, this report’s hydrolysis is carried out under open reflux (i.e. the 
volume is not constant throughout the reaction; see Section 4.4 for complete experimental procedure). 
Using batch kinetics, we can relate the rate of the produced amino acid (NP) to the reaction volume (V) 
and then estimate the influence of the volume change on a general rate of reaction (with k as the reaction 
constant and α as the reaction order), as shown in Equation 5. 
𝑑𝑁𝑃
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Since a first order assumption was shown to provide high correlations with the previous work 
cited, it will also be used here, meaning there would be no influence from the reaction volume on the 
overall rate of the reaction and the validated model94 should be suitable.   
Non-Amino Acid Compounds 
Apart from glucose and its dehydration kinetics31, there is very little other research into how the other 
components present in the yeast extract could possibly react. 






Glucose and its expected products, levulinic and formic acids, will most likely have near first order reaction 
kinetics31 (making them also unaffected by the open reflux system). While levulinic acid is stable 
throughout acidic hydrolysis31, formate would be susceptible to degradation, modeled as a first order 
reaction. These will be the only components modelled by coupled ODEs, as presented in Equations 4-6, 









= ℎ𝑓𝑜𝑟𝐶𝑔𝑙𝑐 − 𝑑𝑑,𝑓𝑜𝑟𝐶𝑓𝑜𝑟 
This modelling choice should help to highlight some key aspects of the dehydration mechanism. 
Previous reports have suggested that very little of the intermediates accumulate during these reactions31. 
However, since there is severe material degradation into humins as well, using the concentration of 
glucose to drive all the reactions with independent reactions rates provides insights into the relative 
production rates without requiring the ability to measure the intermediates. 
Other Components 
For all the other components, visual inspection of their time course profiles provide the first insights into 
potential reaction mechanisms. Compounds showing an increasing trend and reaching their maximum 
concentration will be modelled similar to the amino acids, solving for the initial amount, and the hydrolysis 
and destruction coefficients.  If a compound fails to reach a maximum value, a zero order assumption is 
used to model the initial leg of the true reaction.   Compounds only showing a decrease will be modelled 
by a simple first order power law presented in Equation 9 (i.e. the same as the amino acids but with the 




All parameter estimation was performed using the MATLAB lsqnonlin and ode45 built-in functions (where 








4.0 Materials and Methods 
4.1 Materials 
Yeast extracts were purchased from ThermoFisher Scientific (Massachusetts, USA) and BD Biosciences 
(California, USA). Sf-900III media was purchased from ThermoFisher. All other components were 
purchased from Sigma-Aldrich (Missouri, USA) and were of the highest cell culture grade available. For 
the yeast extract products, three were ThermoFisher lots (Product: BP1422; FL1 [Lot: 163398], FL2 [Lot: 
171921], and FL3 [Lot Unknown]) and one was a BD Biosciences lot (Product: 255772; BD [Lot: 6286813]). 
Sf-9 cells were purchased from ThermoFisher and cultures undergoing less than 50 passages were 
routinely maintained in the lab in Sf-900III medium.  
4.2 H-NMR Spectroscopy 
The method for H-NMR spectroscopy is the same as detailed in Sokolenko71. Samples were prepared by 
adding 70 µL of internal standard to 630 µL aqueous mixture for analysis. The standard used is 5 mM DSS 
(or 4,4-dimethyl-4-silapentane-1-sulfonic acid) dissolved in 99.9% D2O with 0.2 w/v% sodium azide as an 
antimicrobial (supplied by Chenomx Inc., Edmonton, Canada). Sample solutions were vortexed and 
pipetted into 5 mm glass NMR tubes (NE-UL5-7, New Era Enterprises Inc., Vineland, NJ). Samples were 
scanned on a Bruker Avance 600 MHz spectrometer with triple resonance probe (TXI 600). Scans used the 
first increment of a 1D-NOESY pulse sequence with a 1 s pre-saturation pulse, 100 ms mixing time, and a 
4 s acquisition. Spectra were analyzed using Chenomx© NMR Suite© 8.3 (Chenomx Inc., Edmonton, 
Canada). Baseline and phase corrections were first performed automatically by the software, then 
manually adjusted by a human operator, if necessary. The software is a targeted-profiling spectrum 
software containing a large database of idealized peaks for a variety of components, allowing for a human 
operator to manually fit convoluted peaks. Further, the software allows the creation of new compound 
profiles created by the user to expand their database for specific purposes. When analyzing samples from 
a time-course, the correction method developed by Sokolenko71 was applied to the data in order to 
minimize the error associated with systematic sampling bias. On occasion, the spectra were profiled by a 




4.3 Statistical Analysis and Quantification in Hydrolysates 
To determine whether the complex yeast extract solution would impart a higher degree of uncertainty in 
an NMR scan, three solutions of 10g/L were made by dissolving 0.5 g from one ThermoFisher lot (FL3) and 
adding 49.5mL of Milii-Q water and scanned in quadruplicate. Lot comparison was performed with four 
solutions each of the four yeast extract lots available subjected to duplicate scanning.  The solutions and 
their spectra were statistically analyzed based on the resulting quantification ANOVA, as well as principal 
component analysis. Principal component analysis (PCA) is a multivariate statistical technique which 
models observations with inter-correlated variables as orthogonal, unrelated components to determine 
how alike the observations are or to be used as a model for future predictions83. All PCA was performed 
with R software using the RStudio interface and the ggplot2 and FactoMiner packages.  
Compound identification and quantification was performed on both dilute (10g/L) and 
concentrated (>80g/L) solutions. This was to analyze how significantly the hydrolysate concentration 
contribute to the overall quantification of the spectra.   
4.4 Acid Digestion Method 
Acid hydrolysis of yeast extract was carried out according to classical procedures14. Yeast extract was 
digested in 6M HCl with 0.02 w% phenol. To see how the yeast extract responded during the reaction, a 
time course procedure under open reflux conditions was established. The high salt content of the native 
digestion solution upon neutralization would make analysis via NMR more difficult (i.e. all the ions 
interfere with the matching and shimming of the sample due to ionic strength) and thus the following 
protocol was established.  
50mL of 12M HCl was added to the reactor, its mass was recorded, and was stirred on a magnetic 
hot plate set to 3000C. Next, 40mL of a 100 g/L yeast extract solution and 10mL of a 0.2w% aqueous phenol 
solution were added to a 50mL Falcon™ tube and the total solution mass was recorded. The yeast extract 
solution was placed in a hot water bath (~700C) as the reactor was brought up to temperature. When the 
HCl began to boil (~500C), the yeast extract solution was added. The solution was maintained at a visual 
boil (~1100C). These volumes were chosen in order to minimize the risk to the experimenter as well as the 
amount of material required for a digestion. The reaction was halted after a specified time by placing the 
reactor in an ice-water bath until its temperature equilibrated. An appropriate amount of 6M HCl was 
added to reacquire the initial starting mass of the digestion solution and a 1mL sample was withdrawn 




the sample and reduce the total amount of salt for NMR analysis. Additionally, the neutralization and 
dilution create ideal conditions to flocculate the humins and allow them to precipitate easier from the 
solution. The samples were centrifuged for 2 min at 2000 x g to pellet the humins as they interfere with 
the NMR analysis. In order to perform a time-course experiment without significantly affecting the total 
initial material in the reactor, batch reactions were performed for the length of the time point required. 
Since being performed under open reflux instead of in sealed containers, the volume of the solution was 
adjusted by adding about 10g of 6M HCl per hour to counteract the evaporation. The experiment was 
performed in triplicate. 
4.5 ICP Analysis 
The various yeast extracts were analyzed using ICP OES for 20 compounds: Mn, Fe, Ca, Cu, Zn, Na, Ni, Pb, 
Mg, K, Al, Ba, B, Cd, Cr, Co, Li, Sr, Si, and V. The samples were prepared by adding yeast extract to ultra-
pure water and using an aqua regia digestion at 1000C to remove the organic components, leaving the 
inorganic components for analysis. Spectra were analyzed on a Prodigy Higher Dispersion ICP (Teledyne 
Leemans Labs, New Hampshire, USA). The results were compared to the minimum detection limits of 
blank runs to eliminate results that may have been attributed to background noise. Stocks of aqua regia 
were made by mixing pure hydrochloric and nitric acids in a 4:1 volumetric ratio. When required, samples 
were diluted with ultra-pure water from a Simplicity® water purification system (Sigma-Aldrich). 
4.6 Cell cultures 
Cell cultures were performed the same as Sokolenko et. al71. Briefly, Spodoptera frugiperda (Sf9) cells 
were grown in shake flasks at 27 °C and 130 RPM using a fortified IPL-41 medium and commercial Sf-900III 
medium. The cells were routinely split to 0.6 x 106 cells/mL upon reaching a concentration of 2-3 x 
106 cells/mL, with experiments carried out on cells that have undergone less than 50 passages. A 250 mL 
mother flask was seeded at 0.6 x 106 cells/mL with a working volume of 70 mL and grown up to 2-3 x 
106 cells/mL. This flask was used to seed 125 mL flasks at 0.6 x 106 cells/mL at a working volume of 35 mL. 
Cells were counted and sampled for NMR every 24 h until reaching their maximum concentration. Cell 
counts were performed using 0.05% trypan blue in PBS, and counted on a hemocytometer. Trypan blue 
stains inactive cellular membranes, and thus provides a good indication of live or dead cell material during 
manual counting.  The 1.5 mL samples of cell culture media were centrifuged for 10 min at 250 g, with the 
supernatant stored at -80 °C until analysis. Adapting the cells to new media was generally achieved by 




viability (i.e. the first passage was into media 50% Sf-900III and 50% new media, and all subsequent 
passages were in 100% new media).  
For the various metabolic studies, one lot of basal media was used for FL3, while a second lot was 
used for FL1, FL2 and BD. This was due to FL3 being exhausted in the lab before the other yeast extracts 
had been obtained. 
4.7 Media Preparation 
Large batches of media were prepared by dissolving the appropriate amount of amino acids, salts, and 
sugars into approximately 700 mL of ultra-pure water (University of Waterloo E6 custom ultra-pure water 
filter, Durpro, Quebec, Canada) (R>17MΩ). Concentrates of lipids (Chemically Defined Lipid Solution 1, 
Sigma-Aldrich), Cys/Tyr, trace metals, and vitamins (all three solutions were made in house with chemicals 
purchased from Sigma) were then added and the solution was stirred for approximately 30 min without 
heating.  The pH was adjusted to 6.2-6.4 with approximately 10mL of 2.5M NaOH and the solution volume 
was increased to 1 L using a volumetric flask. The solution was sterile filtered with a 0.2 µm PES vacuum 
filter into a sterile bottle. Media was stored at 40C and always less than 6 months old. The chemically 
defined basal medium was a fortified IPL-41 medium containing several improvements from various 
metabolic studies. This medium was designated the Aucoin Lab Insect-cell Medium, or ALIM. The 




5.0 H-NMR Analysis of Yeast Extract  
These results are separated into two main sections. Section 5.1 will analyze the variability imparted by the 
H-NMR spectral quantification of a 10 g/L solution of yeast extract (specifically lot FL3) without 
acknowledging the appropriateness of the qualification of those peaks. Section 5.2 will analyze the 
variability between the lots, as well as providing a biological rational for each of the qualified compounds.  
5.1 Statistical Analysis of Yeast Extract  
In total, 50 compounds were identified in the 10g/L solutions and were used to determine the statistical 
variation between separate scans and solutions of yeast extract. These compounds were also compared 
to their levels found in more concentrated yeast extract solutions. 
Figure 5.1a-d presents the boxplots for the compound concentrations and their variance between 
solutions. ANOVA highlighted only two statistically different compounds: glucose in solution C was 
different than A and B (which were not different from each other); and lactate was different between 
solutions A and B (neither were different from C). When the overall averages are examined (Table 5.1), 
glucose has a CoV of less than 5%, well within the expected error range; lactate is much larger at over 15% 
due to it being in a heavily convoluted location on the spectrum. Overall, compounds present at greater 
than 0.1 w% generally have a CoV of less than 10% and allow for accurate qualification in a 10g/L solution. 
Due to the trace levels of some components, more concentrated yeast extract solutions were 
made to boost the signal intensity. Figure 5.2 displays the amount quantified in the more concentrated 
scan as compared to the dilute (1%) solution. On average, the higher concentrated solutions quantified 
about 90% of that determined from the 1% solutions. Only a few components did not consistently quantify 
within 25% of the detected amount in the 1% solutions: Arg, His, Lys, sarcosine, pantothenate, methanol 
and ornithine. This bias should mean that multiple concentrations of a complex solution should be 
analyzed in order to have a clearer quantification process. However, while this bias can be worrisome, the 
higher solution concentrations do reveal new compounds because of the increase in their absolute 
abundance and now allow for detection (if these peaks are in un-convoluted regions of the spectrum; as 




Table 5.1: Overall average weight percent of the quantified components: YX-FL3 – 10g/L. Italicized components are of 
low qualification confidence due to heavy peak convolution or near the apparent LDL. Yellow: CoV>5%; Red: CoV>10%. 
*a-glycerophosphocholine 
  Amino Acids W% CoV Sugars W% CoV Micronutrients W% CoV 
Alanine 3.39% 3.25% Glucose 0.56% 3.65% 4-Aminobutyrate 0.10% 3.36% 
Arginine 1.72% 2.27% Trehalose 4.49% 2.34% Betaine 1.22% 2.33% 
Asparagine 1.71% 2.17% Total 5.05%  Glycerol 0.08% 7.51% 
Aspartate 2.20% 2.84%    Ornithine 0.18% 4.55% 
Cystine 0.06% 21.90% Nucleic Material W% CoV Sarcosine 0.01% 13.14% 
Glutamate 7.12% 3.07% Adenine 0.02% 10.18% a-GPC* 0.30% 3.03% 
Glutamine 0.37% 5.32% Adenosine 1.35% 2.14% Total 1.88%  
Glycine 1.48% 3.41% Cytidine 0.05% 15.21%    
Histidine 0.73% 2.94% Guanosine 0.14% 3.02% Organic Acids W% CoV 
Isoleucine 2.64% 3.02% Hypoxanthine 0.04% 6.76% Acetate 0.41% 4.44% 
Leucine 3.77% 2.60% Inosine 0.02% 16.13% Formate 0.03% 5.96% 
Lysine 1.91% 3.15% Uracil 0.16% 3.43% Lactate 0.06% 15.82% 
Methionine 1.02% 2.27% Uridine 0.35% 6.16% Succinate 0.60% 2.33% 
Phenylalanine 2.43% 2.58% Total 2.13%  Total 1.10%  
Proline 0.95% 2.81%       
Pyroglutamate 1.52% 3.62% Vitamins W% CoV Alkylates W% CoV 
Serine 2.18% 4.06% Choline 0.03% 4.20% 2-Hydroxyisobutyrate 0.01% 8.70% 
Threonine 2.09% 2.40% Niacinamide 0.06% 6.20% 3-Hydroxyisovalerate 0.06% 4.51% 
Tryptophan 0.70% 2.09% Nicotinate 0.05% 7.31% Butyrate 0.09% 6.23% 
Tyrosine 0.66% 3.12% Pantothenate 0.12% 9.58% Isobutyrate 0.16% 3.05% 
Valine 2.96% 3.63% myo-Inositol 0.13% 14.08% Total 0.32%  
Total 41.62%  Total 0.38%  
 
  

























Figure 5.2: Quantification between dilute (10 g/L) solutions and more concentrated solutions (80 g/L for BD and FL3; 
100g/L for FL1 and FL2. Black line: y = x; blue line: trendline with 95% confidence limits  
 
5.2 Compound Identification and Quantification 
In total, 60 compounds were qualified in the yeast extract, 42 of them with high confidence, as detailed 
in Table 5.2. 
Table 5.2: Identified components in all yeast extract lots. Italicized components are of low qualification confidence 
due to heavy peak convolution or near the apparent lower detection limit (LDL) 
Amino Acids Sugars Nucleic Material Organic Acids 
Alanine Lysine Glucose Adenine Acetate 
Arginine Methionine Trehalose Adenosine Citrate 
Asparagine Phenylalanine  Cytidine Formate 
Aspartate Proline Micronutrients Guanosine Fumarate 
Cystine Pyroglutamate 4-Aminobutyrate Hypoxanthine Lactate 
Glutamate Serine a-GPC Inosine Succinate 
Glutamine Threonine Betaine Uracil trans-Aconitate 
Glycine Tryptophan Ethanol Uridine  
Histidine Tyrosine Glycerol Vitamins Alkylates 
Isoleucine Valine Methanol 4-Pyridoxate 2-Hydroxyisobutyrate 
Leucine  Ornithine Choline 3-Hydroxybutyrate 
  Sarcosine myo-Inositol 3-Hydroxyisovalerate 
  Trigonelline Niacinamide Butyrate 
   Nicotinate Isobutyrate 





A wide cross section of a variety of biological classes were obtained: amino acids, sugars, nucleic 
material, vitamins, organic acids, and other active biological molecules. Figure 5.3 presents the lot-to-lot 
variability of the yeast extracts, broken into rough quantity bins depending on the level quantified. Overall 
contribution based on these identified biological groupings are shown in Table 5.3 
Table 5.3: Overall contributions of the biological groups for each yeast extract lot (w%). 
 BD FL1 FL2 FL3 
Alkylates 0.24 0.28 0.29 0.37 
Amino Acids 38.86 41.66 39.83 41.68 
Micronutrients 3.52 1.65 2.10 1.88 
Nucleic Material 1.60 1.64 1.71 2.15 
Organic Acids 1.19 1.19 1.31 1.13 
Sugars 5.94 10.48 10.13 5.04 
Vitamins 0.63 0.38 0.39 0.41 
Total 51.98 57.29 55.77 52.68 
 
5.2.1 Amino Acids and Sugars 
All twenty standard amino acids were found, along with pyroglutamate. Pyroglutamate is produced from 
phosphate reacting with glutamine and is most likely formed during the production of the yeast extract. 
These compounds were expected to be present, and results are similar to the values previously cited16. 
Only cystine and glutamine quantification are uncertain due to being near the LDL. Glucose and trehalose 
were the main sugars quantified but there were drastic differences in the trehalose content between the 
four lots, which could be an indication of altered biomass growth or downstream processing of the yeast 
extract. 
5.2.2 Organic Acids 
A few TCA cycle intermediates were identified; of them, citrate was the least confidently quantified. Even 
though fumarate and trans-aconitate were only detected at the higher concentrations, the observed 
peaks are not convoluted with any others, lending them relatively higher confidence. Formate and 
acetate, although not a part of the TCA, are integral organic acids in a variety of reactions. Both 
compounds have a single peak, but still allow relative confidence in their quantification (acetate is slightly 
convoluted but not to a concerning degree). Lactate is present as by-product of the TCA or produced by 
lactic-acid bacteria contamination of the hydrolysate lot82. The lactate readings are highly variable, and its 





Several B-Vitamins were identified, in agreement with other reports33, 34. Vitamin B3 (as nicotinate and 
niacinamide) was confidently identified, whereas vitamins B5 (pantothenate) and B6 (as 4-pyridoxate) 
were tentatively quantified due to the convolution of their peaks. Further, myo-inositol and choline, which 
have historically been considered B vitamins were also identified. Overall, the identified vitamins account 
for about 0.5 w% of the yeast extract, or about 20 mg. As a contrast, these vitamins are only added to IPL-
41 at a total mass of 1mg. With the many functions performed by the vitamins, an over 20x reduction in 
the overall vitamin levels should have a detrimental impact on the growth of a culture when grown 
without yeast extract.  
5.2.4 Nucleic Material 
A significant amount of nucleic material was also quantified in agreement with previous reports76, 77. In 
this study, adenosine, uridine and uracil were confidently profiled, whereas all the others have 
considerable uncertainty. Further, there were several areas of the spectrum around identified nucleic 
material with clear peaks but could not be identified. From their location and shape, they could be 
indicative of more material containing nucleic components (more evidence of this can be seen in the time-
course study in Section 5.1.3). Since ribose and nucleotides are not supplied in the basal medium, this 
material would allow the cell to have an active pool of nuclear metabolites immediately available (possibly 
allowing for a quicker adaptation and faster growth as cellular resources do not have to be diverted to 
create these compounds) or as they could be acting in some signaling capacity informing the cell of the 
quality of its surroundings.  
5.2.5 Other Biological Components 
Betaine, choline, and sarcosine are related compounds active in a variety of ways, notably in glycine 
metabolism and as a head group in phospholipids. Betaine and choline were profiled with high accuracy 
whereas sarcosine only has one unconvoluted peak. Ornithine is a non-standard amino acid and an 
intermediate product when arginine is converted into putrescine (a polyamine). Since several reported 
chemically defined media require the addition of a polyamine66, 67, the ornithine could be acting in this 
capacity. Glycerol is essential to the production of phospholipids required for the various membranes of 
the cells. While it could potentially be added to media formulation, the separate lipid supplementation 




glycerophosphocholine (a-GPC) in the BD lot as compared to the FL lots. Since a-GPC is a major storage 
molecule for choline in yeast cells, the significantly higher levels could indicated that the BD growth 
medium contains significantly more choline than the medium used in the FL lots.  
5.2.6 Alkylates 
The final group of identified compounds, designated the alkylates, are highly suspect except for butyrate. 
The other compounds are present in very low quantities, or only have one unconvoluted peak. While 3-
hydroxyisobutyrate and 2-hydroxyisovalerate are known to be active in a couple of yeast metabolic 
pathways, the others do not have any specific role. More likely, these components are place holders in 
the analysis for other methyl or ethyl groups on otherwise unidentified compounds. Therefore, while they 






Figure 5.3a: Lot variation of amino acids and sugars. Components levels are based on 10g/L solution concentrations:  “High”: >2%; “Low”: 2%< x<0.1%; “Trace” : 






Figure 5.3b: Lot variation of nucleic material, organic acids and vitamins. Components levels are based on 10g/L solution concentrations: “High”: >1%; “Low”: 






Figure 5.3c: Lot variation of micronutrients and alkylates. Components levels are based on 10g/L solution concentrations: “High”: >1%; “Low”: 1%<x<0.1%; 




5.3 Principal Component Analysis 
As stated in Section 4.3, PCA can be used to determine how alike a group of observations are83. By using 
it on the quantified components in yeast extract, it should be able to distinguish the major differences 
from various scans of the same solution, as well as how different the various lots of yeast extract are.   
5.3.1 Analysis of Scanning Variation 
Eight principal components accounted for 89% of the variance. As the solutions were all of the same lot 
of yeast extract, a high number of components indicates a very similar dataspace and the model is 
overcompensating to fit the data due to random error83. Figures 5.4 - 5.6 represent the compound 
loadings and Figures 5.7 – 5.9 represent the solution scores for the first three components only (49.0% of 
the total variance). Table 5.4 documents the most variable compounds, while Table 5.5 documents the 
most variable scans for each of the first three components. 
Table 5.4: Top five variable variance contributions for the first three principal components, single lot analysis 



































Table 5.5: Top five individual variance contributions for the first three principal components, single lot analysis. ID 
format: Solution-Scan  
Component     
1 B4 (52.0%) B1 (15.4%) C1 (11.4%) C2 (10.3%) 
2 A1 (35.6%) B4 (16.6%) C3 (14.4%) B1 (12.0%) 






















Figure 5.7: First and second principal component scores for the scanning variance analysis. Scans: 1-4: solution A; 5-8: solution B; 9-12: solution C. Ellipses 





Figure 5.8: First and third principal component scores for the scanning variance analysis. Scans: 1-4: solution A; 5-8: solution B; 9-12: solution C. Ellipses represent 





Figure 5.9: Second and third principal component scores for the scanning variance analysis. Scans: 1-4: solution A; 5-8: solution B; 9-12: solution C. Ellipses 




As expected, PCA for the FL3 solutions show heavy clustering across the first three components; 
solution 8 (Sample B4) is the most significant outlier (as it accounts for 52% and 16% of the variation in 
the 1st and 2nd components respectively [Table 4.5]). During processing, Sample B4 had a worse shim on 
the spectrum than the other samples, meaning there would be more uncertainty in its quantification 
(overall, its quantification error was in the typical ranges expected for each compound when compared 
to the overall average of the three solutions). This shows that when performing PCA on spectra, 
preprocessing is crucial in order to eliminate as much variability as possible. However, it can still be seen 
that the loadings are relatively evenly dispersed across the first three components and the average scores 
for all the three solutions are within the 95% confidence ellipses for each other, indicating an insignificant 
difference between the solutions overall. Further, all of the most variable compounds (contribution >0.6 
in Figure 5.4) have at least one or two unconvoluted peaks, removing this as a potential error source. 
5.3.2 Lot-to-Lot Variation 
The lot-to-lot variation was determined by incorporating both the lower and higher concentrations of 
yeast extract scans. Here, 6 components account for over 90% of the variation, indicating a more diverse 
dataspace than the single lot analysis83. Figures 5.10 - 5.12 represent the compound loadings and Figures 
5.13 – 5.15 represent the solution scores for the first three components (77.3% of the total variance). 
Table 5.6 documents the most variable compounds, while Table 5.7 documents the most variable scans 
for each of the first three components. 
Table 5.6: Top five variable variance contributions for the first three principal components, lot comparison 



































Table 5.7: Top four individual variance contributions for the first three principal components, lot comparison. Sample 
ID format: Brand-Concentration(g/L)-Scan. Asterisk indicates the spectrum was profiled by the second operator 





























































There is a clear separation between the BD and FL yeast extracts between the 1st and 2nd 
components as well as a possible separation between the 2st and 3rd components. The separation in the 
1st and 2nd components is a mainly a result the vitamin differences (niacinamide, a-GPC, choline, myo-
inositol), but accounts for the other most variable components between the yeast extracts (glucose, 
betaine, adenine, etc.). Although all of the FL seem to be more similar to each other than to the BD lot, 
their wide spread across the 1st and 2nd components is most likely due to the drastically different levels of 
trehalose in FL1 and FL2 as compared to FL3. The separation in the 2nd and 3rd components could be also 
be due to the significantly different trehalose levels between all the lots tested. Most of the overlap 
between Table 4.4 and Table 4.6 is due to those compounds having significantly different levels between 
lots, and is not an indication of any interactions between NMR and PCA. 
In all cases, the higher concentration scans had lower scores for that yeast extract. Since a 
minority of compounds have loadings in the third quadrant, the shift towards this side indicates the 
analysis determining a lack of the compounds in the first quadrant, as was previously established when 
comparing the relative concentrations in Section 5.1. While the sample concentration influenced the PCA, 
the operator who profiled the spectrum does not. In Figures 5.13 – 5.15, scan numbers 40-47 were spectra 
quantified by a separate operator, and yet they overlay nearly exactly with those performed by this 
author. However, this does not mean the operators’ results were identical; some of the more minor 
components have a variety of potential peak options in the spectra and thus their location must be 
standardized between operators for more accurate quantification. Since the majority of the peaks were 
identically assigned by both operators, PCA was unable to distinguish the minute differences between the 
scans, even though it could detect the minor variations in the multiple yeast extracts profiled by a single 
operator. This shows the strength of using PCA for lot screening as the operator does not impart enough 




6.0 ICP Analysis of Yeast Extract 
In order to determine the variability in the ICP reading due to a complex solution, individual concentrated 
solutions of Co, Fe, Mn, Cu, and Zn salts were created and then combined into one solution at a 100-fold 
dilution. All six solutions were subjected to ICP analysis, with the results presented in Figure 6.1. As can 
be seen, the supplied elements behaved accordingly upon dissolution (Figure 6.1a, “High”) but could be 
detected in the other defined solutions, along with several other contaminants not present in any of the 
individual concentrates at the required level seen in the combined solution (i.e. the levels in 6.2b “Low” 
are all pure solutions but do not match 6.2b “High” detections). This tends to suggest that these are not 
true readings in complex solutions and throw doubt into whether these compounds were detected in 
yeast extract. Considering the vast number of non-supplied chemicals detected, more serious 
investigation is required to determine where this is from and if it would in any way be affecting the 
detection in the yeast extract. The most probable explanation for these readings are the contaminants 
are present in any of the waters used to make the yeast extract solution or during the ICP aqua regia 
hydrolysis.  
From the analysis of the 10 g/L solutions, 13 elements were detected, however not every element 
was present in every lot, as shown in Figure 6.2.  
The bulk ions (Na, K, Ca, and Mg) represent very little contribution when compared to the levels 
already supplied in IPL-41 (i.e. 40%, 16%, 5% and 5% respectively). The yeast extract is a majority supplier 
of Co, Fe, Mn, Cu and Zn, and would be the only supplier of Cr, Ni, Si, and V. Compared to the IPL 
supplement, the yeast extract provides significantly more of these trace metals (Mo is the only supplied 
element which cannot be analyzed). Multivalent trace ions (e.g. Fe, Cu, and Mn) are responsible for 
producing free oxygen radicals in media. These radicals cause harm to major biological macromolecules 
and therefore their levels need to be carefully controlled for optimal growth. However, these three all 
have known biological roles, necessitating their supplementation. Except V, none of the elements 
detected in the yeast extract but not already supplied are suspected of having biological roles for Sf-9 cells 
and could be causing more harm than good in the media. The variability in both the quantity and presence 
of a variety of ions can have a wide range of unexpected effects during cell growth and demonstrates a 







Figure 6.1a: Quantification of supplied metals as individual concentrated supplements and their detected level as a 
combined solution. “ALL (100x)” refers to the detected amount in the 100-fold diluted combined solution, but is 
plotted at 100x the detected amount for comparison to the concentrated samples. Error bars are neglected when 
they exceeded the magnitude of the average value. 
 
Figure 6.1b: Quantification of contaminants in concentrated supplements and their detected level in the combined 






Figure 6.2: Detected metal ions along with the IPL-41 trace supplement levels. The IPL-41 trace metal supplement 







7.0 Acid Digestion of Yeast Extract 
As stated in Section 3.2, yeast extract is composed of many different organic bonds and thus acid 
hydrolysis was chosen to digest the base yeast extract. A full time course was studied to ensure the most 
accurate representation of the overall process was achieved. Some components degraded immediately 
whereas others were essentially stable over the analysis. An appropriate kinetic model was chosen based 
on the observed data. Over the duration of the acid hydrolysis, 53 compounds were monitored.  
7.1. Amino Acids 
Amino acids with modelled kinetics are shown in Figure 7.1a, whereas those without modelled kinetics 
are in Figure 7.1b. Table 7.1 presents the estimated initial amount (C0) to show dominant amino acids, 
and Table 7.2 presents the determined hydrolysis constants. 
Table 7.1: Initial estimated amount and its confidence interval for each amino acid with modelled kinetics. Asp and 
Glu were modeled using the total initial amount of Asx and Glx, respectively. 
 Co (w%) Co  CI% 
 Co (w%) Co  CI%  
Aspartate 3.11 2.8 Alanine 0.95 7.9 
Glutamate 3.06 7.0 Isoleucine 0.93 14.7 
Lysine 2.68 6.8 Arginine 0.91 8.1 
Glycine 1.59 5.5 Leucine 0.60 8.1 
Proline 1.56 3.5 Histidine 0.58 7.9 
Threonine 1.46 7.3 Tyrosine 0.52 6.7 
Serine 1.32 10.3 Phenylalanine 0.46 12.8 
Valine 1.13 8.5 Methionine 0.15 52.3 
 
Table 7.2: Estimated hydrolysis rate and its confidence interval for each amino acid with modelled kinetics. Asp and 
Glu were modeled using the total initial amount of Asx and Glx, respectively 
  h (min-1) h CI%  h (min-1) h CI% 
Alanine 0.0325 42.4 Tyrosine 0.0164 24.0 
Glycine 0.0294 27.8 Threonine 0.0151 25.0 
Aspartate 0.0212 11.4 Histidine 0.0144 26.6 
Serine 0.0210 42.1 Lysine 0.0142 22.6 
Phenylalanine 0.0204 51.5 Proline 0.0137 11.4 
Arginine 0.0203 32.4 Methionine 0.0099 148 
Leucine 0.0201 32.4 Valine 0.0097 23.9 











Figure 7.1b: Amino acids experiencing instant degradation. 
As can be seen, most amino acids do not significantly change after 300 min. Since 24 hours is 
recommended for the complete hydrolysis of full length proteins14, the shortened amount of time is 
consistent with having a majority of short oligopeptides present. The hydrolysis constants show a similar 
pattern to that observed by Darragh and Moughan94, with Asp and Ala having the highest rates and Ile 
and Val having the lowest.  
When analyzing the overall change in amino acid levels, it helps to not only look at how its overall 
contribution changes, but how it compares to the total amount of free amino acids detected, as reported 
in Table 7.2. All the post digestion levels are similar to values previously reported for this yeast extract 
product16 to be considered evidence of minor batch-to-batch variation; the degree of hydrolysis (i.e. the 
initial free amino acids to the total free amino acids) is also very similar at 0.66. However, even some 
components with a modest overall increase and are present at the average rate in the peptides (e.g. Ser, 
Val) do not have as significant of a change when compared to the total amino acids. Noting their increases 
in this regard helps to show that Gly, Lys and Pro are more heavily contained in oligopeptides than in the 
initial free amino acids than components like Leu and Phe. Only a limited number of proteases are able to 
hydrolyze Pro linkages77, and therefore its heavy presence in the oligopeptide fractions is expected; the 
increases of Lys and Pro coupled with the high presence of Glx and Asx could be related to previous reports 
that the most bio-active fraction of yeastolate contains a higher proportion of positively-charged side 




Table 7.2: The change in the amino acids, normalized to the overall initial yeast extract and the final free amino 
acid levels. Methionine experiences severe degradation and is most likely present in higher amounts overall. Asp 
and Glu represent Asx and Glx respectively. Highlighted compounds undergo the most significant changes.            
Bo’,i = Bo,i / Bo, total (same for Co’ and To’); %change compares the increase (Co) and total (To)  (i.e. 1 - Bo / To) 
 Overall (w%) Amino acid (aa%) 
 Bo Co To %Change Bo
’ Co’ To’ %Change 
Alanine 3.25 0.95 4.20 22.6 8.10 4.52 6.87 -15.2 
Arginine 1.50 0.91 2.41 37.9 3.73 4.34 3.94 5.7 
Aspartate 3.94 3.11 7.05 44.1 9.81 14.8 11.5 17.5 
Glutamate 8.68 3.06 11.74 26.1 21.6 14.6 19.2 -11.2 
Glycine 1.58 1.59 3.17 50.0 3.95 7.55 5.19 31.4 
Histidine 0.69 0.58 1.27 45.5 1.73 2.76 2.08 20.5 
Isoleucine 2.69 0.93 3.62 25.7 6.71 4.42 5.92 -11.7 
Leucine 3.50 0.60 4.09 14.6 8.71 2.84 6.70 -23.1 
Lysine 2.01 2.68 4.69 57.1 5.02 12.75 7.67 52.9 
Methionine 1.03 0.15 1.18 12.4 2.57 0.70 1.93 -25.1 
Phenylalanine 2.41 0.46 2.87 16.0 6.00 2.18 4.69 -21.8 
Proline 0.85 1.56 2.41 64.7 2.12 7.41 3.94 86.0 
Serine 2.14 1.32 3.47 38.2 5.34 6.30 5.67 6.2 
Threonine 1.91 1.46 3.36 43.3 4.75 6.93 5.50 15.8 
Tyrosine 0.67 0.52 1.20 43.7 1.68 2.50 1.96 16.7 
Valine 3.28 1.13 4.41 25.6 8.16 5.38 7.21 -11.7 
Total 40.1 21.0 61.1 34.4     
 
7.2 Sugars and Conversion Products 
As expected, the acid digestion of yeast extract resulted in the formation of visible black particulate known 
as humins. Trehalose was converted instantly into glucose (its mass is included in the initial glucose 
amount during fitting), which was then slowly degraded into levulinate and formate. Their trends are 
presented in Figure 7.2 with their respective parameters in Table 7.3. 
Table 7.3: Fitted glucose reaction kinetic parameters. 
 h (min
-1) h CI% d (min-1) d CI% 
Formate 0.00517 9.4 0.00245 24.8 
 Bo (w%) Co CI% h (min
-1) h CI% 
Glucose 11.35 4.1 0.0181 7.7 
Levulinate -- -- 0.0104 2.3 
 
As expected, levulinate was stable after production whereas formate degrades. The estimated 
initial amount of glucose (11.35 w%) is very similar to the mass achieved from the measured initial 
amounts of glucose and trehalose combined (11.30 w% as glucose), indicating there is very little, if any, 
glucose contained in other forms before digestion. Overall, about 2.4 mM of glucose were reacted to 




While this study was performed at more dilute concentrations than those documented by Mukherjee et 
al.78, it has a better conversion and yield than most other conditions. Further, this study also used a 
relatively lower amount of additive (i.e. 0.02% phenol) than others. Since phenol was shown to be 
degraded in this study, it would not have any impact during final purification of the levulinate. With the 
increased popularity in producing levulinic acid from biomass feedstock31, it would be worthwhile to see 
if the increased conversion and yield hold for higher glucose concentrations under the phenol addition.  
Even though levulinate and formate are deemed to be formed at the same time when 5-HMF decomposes 
(Figure 3.2), levulinate has a hydrolysis constant almost twice that of formate, suggesting that the 
mechanism for this decomposition first releases levulinate before formate detection. 
 
Figure 7.2: Kinetic trends for the sugars and their conversion products 
7.3 Nucleic Material 
Of the identified nucleic material in the undigested scan, acid digestion expectedly cleaved all the 
nucleotides from their sugars. However, while this happened instantaneously for the purines (adenosine, 
guanosine, and inosine), the pyrimidines (uridine and cytidine) seemed to be much more resilient to 





Table 7.4: Fitted nucleic material kinetic parameters (cytosine is a 0 order model). Hypoxathine was modelled with 
the initial amount determined from the more concentrated scans. 
 
Co or Bo 
(w%) 
Co or Bo 
CI% 
h or d 
(min-1) 
h or d 
CI% 
Adenine 1.30 6.2 0.0012 25.3 
Uracil 0.99 25.7 0.0025 44.2 
Cytidine 0.65 18.1 0.0024 48.9 
Uridine 0.28 14.2 0.0035 32.2 
Hypoxanthine 0.07 27.8 0.0083 72.9 
Cytosine -- -- 0.0004 6.5 
 
 
Figure 7.3: Kinetic trends and parameters for identified nucleic material (cytosine is a 0 order model). Hypoxanthine 
was modelled with the initial amount determined from the more concentrated scans.  
 
The considerable increases in cytosine and uracil heavily suggest that they are main monomers of 
oligonucleoside fragments. No thymidine was detected throughout the study, which, along with the heavy 
presence of uridine, indicates that the nucleosides are mostly from RNA fragments and not DNA, in 




this lends evidence that there are still fragments which have not been hydrolyzed even after 12 hours. 
While a first or zero order assumption fits most compounds well, cytidine is clearly present after 12 hours, 
even though it is an outlier for this assumption. This could be evidence cytidine is also being produced to 
some degree, again implying a significant amount of nucleic material. The most surprising find is that there 
is about twice as much adenine detected at 30 min (0.36 mM) than was expected based on the initial 
adenosine (0.16 mM). Since no other adenine containing components could be identified this could be 
due to residual poly-A tails left over from mRNA fragments.  
7.4 Organic Acids, Vitamins, Micronutrients 
Only acetate, fumarate, glycerol, and myo-inositol had any noticeable kinetics, as shown in Figure 7.6 and 
Table 7.5.  
Table 7.5: Fitted kinetic parameters for other modelled compounds. Fumarate was modelled using the initial amount 
quantified from concentrated yeast extract spectra.  
 
Co or Bo 
(w%) 
Co or Bo 
CI% 
h or d 
(min-1) 
h or d 
CI% 
Acetate 0.56 7.8 0.0018 25.0 
Glycerol 0.061 18.8 0.0056 42.2 
myo-Inositol 0.050 32.9 0.0093 90.3 
Fumarate 0.017 46.3 0.0029 84.4 
 
The initial increase of acetate could be due to the hydrolysis of acetyl ester bonds, although there 
were no significant quantities of any these compounds detected. Most of the glycerol and choline increase 
will come from the conversion of a-GPC. However, since choline experienced an immediate increase 
compared to the more gradual release of glycerol, this implies that the dephosphorylation of 1-
phosphoglycerol is the rate limiting step, as shown in Figure 7.5. Of the initial 13 µmol a-GPC/g-yeast 
extract, only about 5 µmol glycerol/g-yeast extract was detected at the end of the hydrolysis (i.e. 38% 
total hydrolysis), meaning there is probably some residual 1-phosphoglycerol, or that glycerol itself 
decomposes significantly. Conversely, as much as 92% of the choline from a-GPC was quantified, 
suggesting there is no residual choline bonds. As myo-inositol is a common phospholipid head group, its 
increase could indicate there are residual phospholipids in the yeast extract. Phospholipids would also 
provide small amounts of glycerol and serine. It is unknown why fumarate would increase. The initial 
increase of nicotinate is from the conversion of niacinamide, but is still at low overall quantities, resulting 
in its more variable quantification. Although ornithine might also appear to have increased, the readings 




overall decreasing trend, but again the data is too noisy to make any definitive claims. Succinate, betaine, 
and citrate are stable even after 12 hours of acid digestion. 
 
Figure 7.4: Proposed mechanism for the acid hydrolysis decomposition of a-GPC. Charges are assumed to be 
balanced by the abundance of ions in the overall solution. 
 
7.5 Alkylates and Phenol 
Figure 7.7 and Table 7.6 present the kinetic profiles for phenol and the alkylates. 
Table 7.6: Fitted alkylate and phenol kinetic parameters 
 
Co or Bo 
(w%) 
Co or Bo 
CI% 
h or d 
(min-1) 
h or d 
CI% 
Butyrate 0.081 12.0 0.0029 33.7 
Isobutyrate 0.058 27.1 0.0090 53.4 
3-Hydroxybutyrate 0.056 13.4 0.0009 61.3 
Isovalerate 0.030 18.4 0.0036 47.9 
3-Hydroxyisovalerate 0.009 28.1 0.0033 52.7 
Phenol -- -- 0.0262 18.1 
 
As stated previously, only butyrate has any qualification confidence of the alkylates, and therefore the 
accuracy of the other compounds is debatable. Isobutyrate and isovalerate could not be accurately 
modelled, likely due to the only peaks used to quantify these compound becoming obscured heavily after 
90 min. Phenol was completely degraded after 120 min in all cases. Although it appears 3-hydroxyvalerate 
increases over the hydrolysis, all of the values are still within + 10% of the mean, indicating it could be 







Figure 7.6: Kinetics of other compounds during acid hydrolysis of yeast extract. The red lines provide a +10% boundary from the mean value of the scans to show 





Figure 7.7: Kinetics of alkylates and phenol during acid hydrolysis of yeast extract. Phenol is normalized to the 
amount of yeast extract in order to keep units consistent (initial solution concentration is 0.02w%) 
 
7.6 Final Acid Hydrolysis Composition  
A hypothesized composition for FL3 is presented in Table 7.5. To account for the hydrolysis, the following 
was performed: 
 The Bo and Co terms for each amino acid and the other increasing compounds were summed; 
 Compounds undergoing decomposition only were reported as their estimated Bo value; 
 Compounds with no modelled kinetics were reported as the overall average amount; 
 The a-GPC compounds are reported as their individual initial amounts; 
 The estimated Co for adenine, hypoxanthine, and uracil was converted to adenosine, inosine, or 
uridine, respectively, since these are the most likely precursors for these products; and 
 Cytidine was reported as its Bo value. Cytosine was not used in the estimation since it had not 






Table 7.7: Hypothesized initial composition of FL3, weight percent. Glu and Asp account for Glx and Asx, respectively 
Amino Acids w% Sugars w% Organic Acids w% 
Glutamate 11.74 Trehalose 9.78 Succinate 0.75 
Aspartate 7.05 Glucose 1.01 Acetate 0.56 
Lysine 4.69 Total 10.8 Citrate 0.46 
Valine 4.41 Nucleic Material w% Lactate 0.12 
Alanine 4.20 Adenosine 3.71 Formate 0.03 
Leucine 4.09 Uridine 2.36 Fumarate 0.01 
Isoleucine 3.62 Cytidine 0.65 Total 1.9 
Serine 3.47 Inosine 0.18 Micronutrients  w% 
Threonine 3.36 Uracil 0.14 Betaine 0.94 
Glycine 3.17 Guanosine 0.09 a-GPC 0.34 
Phenylalanine 2.87 Hypoxanthine 0.03 myo-Inositol 0.21 
Arginine 2.41 Adenine 0.01 Ornithine 0.16 
Proline 2.41 Total 7.2 Glycerol 0.16 
Histidine 1.27 Alkylates w% Nicotinate 0.11 
Tyrosine 1.20 Butyrate 0.08 4-Aminobutyrate 0.06 
Methionine 1.18 Isobutyrate 0.07 Sarcosine 0.04 
Total 61.1 3-Hydroxybutyrate 0.06 Choline 0.04 
  3-Hydroxyisovalerate 0.05 Total 2.1 
  Isovalerate 0.03   
  Total 0.3 Grand total 83.4 
 
About 83.4% of the yeast extract can be accounted for through acid digestion and NMR analysis. 
Combining this with the ICP results (8.4 w%) brings the total accounted mass up to about 91.8 w% for this 
study. Assuming a similar inorganic anion composition (i.e. PO43-, SO43-, and Cl-) as previously reported for 
this yeast extract product (3.4 w%16) allows for about 95 w% of the material to be determined. With very 
little mass unaccounted for, this indicates that only trace components, and those undetectable by the 
NMR are left unqualified. This proves that H-NMR spectroscopy is a highly useful tool for quantifying 
components in a complex solution with only minimal foreknowledge of possible constituents. 
 As expected, the yeast extract was mostly amino acids and sugars. Surprisingly, there was also a 
very significant amount of nucleic material detected, meaning the initial supplement pool for these 
compounds would be quite significant when using yeast extract for cell culture work. It could be very likely 




8.0 Metabolic Studies 
Many groups have used the same defined basal media with different lots of various yeast extracts without 
seeing significant effects on overall growth. This suggests that the essential compounds for growth can be 
found in a large variety of products, independent of the various production parameters that have been 
employed and improved over the years. However, changes in media composition are known to influence 
cell growth and therefore a more complete metabolic analysis will help to illuminate how the growth is 
influenced by various lots of yeast extract.   
8.1 Yeast extract containing medium 
The metabolism of Sf-9 cells was studied as they grew in Sf-900III, one of the highest performing 
commercial media available, as well as the various in-house media. This is then compared to adapted cells 
in various yeast extracts to see how the metabolism has been influenced. As they are routinely maintained 
in this media, no adaptation period was necessary. 
8.1.1 Commercial hydrolysate-containing media – Growth and Metabolite Trends 
Figure 8.1 presents the growth rate for Sf-9 cells in Sf-900III media. The cells had an average growth rate 
of 0.0225 h-1 and reached an average maximum cell density of 13.5x106 cells/mL. These will be the two 
main statistics used to judge how well the in-house media with various other yeast extracts perform. The 
trends for the 52 identified metabolites are shown in Figures 8.2 – 8.5, while Table 8.1 indicates the 
qualification confidence for each of them. 
Table 8.1: Identified metabolites during Sf-900III cultures. Italicized components are of low qualification 
confidence due to heavy peak convolution or near the apparent LDL  
Amino Acids Sugars Biologicals Organic Acids 
Alanine Lysine Fructose 4-Aminobutyrate 1,3-Dihydroxyacetone 
Arginine Methionine Glucose a-GPC 2-Oxoglutarate 
Asparagine Phenylalanine Maltose Choline Citrate 
Aspartate Proline Mannose Nicotinate Formate 
Cystine Pyroglutamate Sucrose Ornithine Fumarate 
Glutamate Serine Trehalose Sarcosine Lactate 
Glutamine Threonine   Maleate 
Glycine Tryptophan Nucleic Material Others Pyruvate 
Histidine Tyrosine Guanosine Acetone Succinate 
Isoleucine Valine Hypoxanthine Isobutyrate  
Leucine b-Alanine Inosine Ethanol  
  Uracil Methanol  
  Uridine   





Figure 8.1: Growth of Sf-9 cells in Sf-900III media, average of three biological replicates. Vertical line represents the 







Figure 8.2: Trends of amino acids during metabolic studies in Sf-900II media, average of three biological replicates. Vertical line represents the approximate end 





Figure 8.3: Trends of sugars and nucleic acids during a metabolic study in Sf-900II media, average of three biological replicates. Vertical line represents the 





Figure 8.4: Trends of organic acids during a metabolic study in Sf-900II media, average of three biological replicates. Vertical line represents the approximate end 





Figure 8.5: Trends of other biological and profiled compounds during a metabolic study in Sf-900II media, average of three biological replicates. Vertical line 




These profiles are very similar to others found for Sf-9 cells in Sf-900II media108, 109.  
Amino acids 
During exponential growth, the amino acids Ala, b-Alaa, and pGlu increased whereas Asp, Asn and Phe 
stay relatively stable. The rest of the amino acids decreased, but only Cys and Ser are exhausted by the 
end of the culture.  Once exponential growth was over, several amino acids began to accumulate in the 
media. No papers with an extensive metabolic analysis without media replenishment after the growth 
phase concluded could be found making it is hard to validate the trends.  
Sugars 
The Sf-9 cells consumed glucose and maltose and produced fructose and mannose. Sucrose is initially 
present in the media but appeared to be relatively stable over the culture, indicating it is not used at any 
point for energy production, contradicting other reports110. The significant amount of fructose produced 
only occurs when glucose is heavily supplied initially (i.e. cultures with lower initial levels of glucose, like 
the ALIM run in Section 8.1.2, do not produce this fructose). This suggests that the phosphofructokinase 
producing fructose-1,6-bisphosphate during glycolysis is not as active as those able to produce fructose  
and mannose (possibly mannose isomerase). Upregulating the phosphofructokinase genes would provide 
an interesting avenue for enhancing Sf-9 metabolism. 
Nucleic material 
Uridine was rapidly depleted from the media and resulted in a corresponding increase of the uracil, before 
the nucleotide was itself consumed. This indicates that the ribose is actively cleaved from the nucleoside, 
either by uridine ribohydrolase (which simply removes the ribose) or uridine:phosphate alpha-D-
ribosyltransferase (which transfers the ribose to an inorganic phosphate). Similarly, inosine was depleted 
from the media and hypoxanthine was produced. However, as there is more final hypoxanthine than there 
was initial inosine, other mechanisms must be responsible for this discrepancy.  At no point was xanthine 
detected though, indicating that the Sf-9 cells do not have an efficient xanthine dehydrogenase. It is hard 
to rationalize why guanosine would increase and decrease so rapidly but there was higher variability with 
this compound’s spectral location than the other nucleosides and it could indicate that some improper 
qualification has occurred. However, no ribose was detected at any time. Therefore, while it is clear that 
                                                          
a Alpha-alanine is 2-aminopropanoic acid whereas beta-alanine is 3-aminopropanoic acid. These compounds have 
vastly different metabolic pathways and are not directly convertible. It is grouped here since it is still technically an 




the cells are metabolizing the ribose, it is unknown if the hydrolysis is occurring in the supernatant with a 
very quick consumption rate or inside the cell itself followed by nucleotide secretion. 
Organic acids 
Organic acid metabolism in Sf-9 cells was heavily dependent on the stage of the culture. Formate 
increased at a consistent rate regardless of the growth stage, whereas the increase of citrate was 
dependent on the stage of the culture, increasing much more rapidly once exponential growth had 
finished. 1,3-dihydroxyacetone (DHA) and maleate only increased during growth and stayed relatively 
stable during high density maintenance. Conversely, pyruvate, 2-oxoglutarate (i.e. AKG), and fumarate, 
were stable during the growth phase, but increased afterwards before being consumed again. Since 
maleate did not decrease after the growth phase, as noticed with fumarate, this suggests that the maleate 
cis-trans-isomerase is not very efficient in Sf-9 cells (maleate and fumarate are the common names for 
the cis and trans isomers of butenedioic acid, respectively). The profiles for succinate and lactate are 
highly unusual and might be metabolic in nature or they could be a result of the quantified peaks being 
highly variable in spectral location (succinate) and near the LDL (lactate). 
Other biological and profiled components 
Choline and nicotinate both decreased only during exponential growth, but whereas choline was fully 
depleted and then reappeared, nicotinate was stable after growth had finished. These are both explained 
by noting that these compounds are not energy related and are instead related more to the quantity of 
cells (i.e. choline in membranes and nicotinate as a vitamin). Although ornithine clearly decreased over 
the culture, it is hard to pinpoint if it is related to a specific growth stage due to the variable readings, 
unlike 4-aminobutyrate, which only decreased after growth had finished. Sarcosine can be created either 
through the methylation of glycine or the oxidation of choline to betaine and its demethylation into 
sarcosine. Of the other identified compounds, only isobutyrate was metabolized; all the other compounds 
were relatively stable over the culture.  
8.1.2 ALIM Lot 1 with FL3 – Growth and Metabolite Trends 
Figure 8.6a presents the adaptation of Sf9 cells in ALIM-4FL3 (i.e. ALIM media with 4g/L of FL3 yeast 
extract), while 8.6b focuses on the growth rate for the 8th passage (which was used for the metabolic 
study). The cells had an average growth rate of 0.0203 h-1 and a maximum cell density of 9.7 x 106 cells/mL, 




similar, the larger difference between the maximum cell densities and overall culture duration is due to 
glucose exhaustion after 7 days49. 
 
Figure 8.6b: Growth of Sf-9 cells in ALIM-4FL3 media after adaptation, average of four biological replicates. Circle: 
growth; triangle: viability. 
In total, 52 compounds were profiled over the duration of the culture, 38 of which have 
reasonable certainty in their qualification (Table 8.2). Some compounds which had high confidence in their 
qualification for just the yeast extract scans became more convoluted due to the higher concentration of 
the amino acids and sugar (e.g. ornithine and acetate). The culture only lasted one day after exponential 
growth (i.e. the cultures were all dead on day 9). All metabolite trends can be found in Figures 8.7 – 8.10. 
Table 8.2: Identified metabolites during ALIM cultures. Italicized components are of low qualification confidence due 
to heavy peak convolution or near the apparent LDL 
Amino Acids Sugars Biologicals Organic Acids 
Alanine Lysine Glucose 4-Aminobutyrate Acetate 
Arginine Methionine Trehalose Betaine Citrate 
Asparagine Phenylalanine . Choline Formate 
Aspartate Proline Nucleic Material Glycerol Fumarate 
Cystine Pyroglutamate Adenine Nicotinate Lactate 
Glutamate Serine Adenosine O-Phosphocholine 
Glutamine Threonine Cytidine Ornithine Others 
Glycine Tryptophan Guanosine Sarcosine 3-Hydroxyisovalerate 
Histidine Tyrosine Hypoxanthine Succinate Isobutyrate 
Isoleucine Valine Inosine a-GPC Ethanol 
Leucine b-Alanine Uracil 1,3-Dihydroxyacetone Methanol 





Figure 8.6a: Adaptation of Sf-9 cells in ALIM-FL3 media, average of two or four biological replicates. Circle: growth; triangle: viability. Connected points are of the same growth 





















Figure 8.10: Trends of other profiled compounds during metabolic studies in ALIM-FL3 media, average of four 
biological replicates.  
Amino Acids and Sugars 
Only three amino acids show any significant increase during the culture: n- and β-alanine are metabolic 
by-products whereas pyroglutamate is a result of glutamine destruction. Of the remaining amino acids, 
only cystine and glutamine show close to a 50% reduction. Glutamine is a dominant carbon source for 
insect cells and so its reduction is expected. Cystine is the lowest supplied amino acid at less than 1 mM 
and this could be the reason why it has a more significant reduction compared to the other amino acids 
which are mostly supplied above 5mM. Overall, the trends closely mimic those in Sf-900III. Although no 
amino acids were completely exhausted, in most instances there was a more significant reduction after 
day seven, the time of the noticed glucose exhaustion. Therefore, with higher glucose supplementation, 
it could be possible to encounter glutamine exhaustion. However, excessive glucose increases the 
production of lactate, alanines and fructose, which are only consumed upon glucose exhaustion (as can 
be seen from the Sf-900III metabolite trends). The amino acid profiles compare reasonably well between 
the ALIM and Sf-900III cultures during exponential growth. 
Nucleic Material  
The cells seemed to metabolize the nucleosides and eventually secrete their respective nucleoside except 




detected at any point (guanine cannot be quantified by H-NMR so it is unknown if this is also increasing). 
Adenine is unique as it is secreted for the first couple of days before being metabolized. This could be due 
to the initial cells metabolizing the ribose from adenosine and having an excess of adenine, before the cell 
density is large enough to have a noticeable adenine metabolism. There was also a shift from having 
adenosine and little inosine in the media initially to very little adenosine and a lot of inosine after only 24 
hours. All nucleosides increased on day 8, indicating that they are released from the cells during lysis. 
Most of the differences between these and the Sf-900III trends are due to the much lower initial supplied 
levels. 
Organic Acids and Other Biological Compounds 
A majority of these compounds show dramatic increases over the duration of the culture. Lactate is known 
to be produced by the cell in response to glucose metabolism; upon glucose exhaustion, the cell further 
metabolizes the lactate. Glycerol may be from glycolysis or fatty acid metabolism but either way, it also 
shows a heavy depletion after day seven meaning it could have been re-introduced into glycolysis as 
glycerol-3-phosphate after glucose exhaustion. The other TCA components are most likely present in the 
supernatant due to the cell producing a more than sufficient quantity for its needs and allowing a small 
amount to be excreted, but only fumarate and succinate show a noticeable decrease coinciding with 
glucose exhaustion. While betaine seems to be metabolized by the cell, its related compound choline is 
heavily used. The final combined amount of o-phosphocholine and sarcosine represents about half of the 
initial starting choline, suggesting that the choline is converted to these products and excreted, while the 
remainder is presumably used as a phospholipid head group. Succinate presents an interesting trend as it 
seems to be used over the initial growth of the culture but then it is excreted during the later stages. 
Other Profiled Compounds 
Four other compounds do not fit neatly into the above categories and thus have been separated. Ethanol 
is supplied in the lipid solution, whereas methanol could possibly be present as a contaminant (but more 
likely it is due to the spectral peak being improperly qualified). Although a decreasing trend can be fitted 
to ethanol, it only changes by about 6% over the course of the culture, well within the expected error for 
H-NMR, and therefore its trend could be a random outcome of the profiling. While 3-hydroxybutyrate 




 Overall, the general trends obtained with ALIM-FL3 mimicked those observed with the Sf-900III 
media, confirming the hypothesis that the components necessary for growth are contained in a variety of 
hydrolysate lots and suppliers. 
8.1.3 ALIM Lot 2 with FL1, FL2 and BD Yeast Extracts 
As stated in Section 4.7, two different lots of ALIM were used due to not having the studied yeast extracts 
in the lab at the same time. While the media is completely chemically defined apart from the yeast extract, 
different lots of the defined lipid solution (purchased from SigmaAldrich) were used. Although it is hoped 
that the defined solution is made to the same standards every time, noticeable variability in the 
appearance of the solution was experienced by multiple users in the lab and it is unknown how this could 
affect lipid solubility and overall efficacy of the product. Therefore, these results are being presented with 
the major underlying assumption that the lipid solution was of similar quality and resulted in the same 
amount of overall lipid supplementation. 
Figure 8.11 to 8.13 present the adaptation of Sf9 cells into ALIM with 4g/L of FL1, FL2 or BD yeast 
extracts, respectively. 
 
Figure 8.11: Adaptation of Sf-9 cells in ALIM-4FL1 media. Circle: growth; triangle: viability. Connected points are of 







Figure 8.12: Adaptation of Sf-9 cells in ALIM-4FL2 media. Circle: growth; triangle: viability. Connected points are of 
the same growth passage before being re-suspended into 25% new media (passage 5 would be of negligible residual 
Sf-900III) 
 
Figure 8.13: Adaptation of Sf-9 cells in ALIM-4BD media. Circle: growth; triangle: viability. Connected points are of 
the same growth passage before being re-suspended into 25% new media (passage 5 would be of negligible residual 
Sf-900III) 
None of these yeast extracts were able to achieve growth above 2x106 cells/mL after 4 or more 
passages. The major reason for this (again ignoring any potential issues from the lipid solution) would be 




since FL2 and FL3 have a much higher weight percent of trehalose, other components would be affected 
negatively and show a small reduction in their contribution. While this may not be an issue for amino 
acids, sugars or ions more heavily provided by the defined basal medium, it could significantly affect trace 
components heavily provided by yeast extract. Therefore, 8g/L of yeast extract was tried in order to see 
if this would boost those trace components into active ranges, as documented in Figures 8.14 to 8.17. 
 
Figure 8.14: Adaptation of Sf-9 cells in ALIM-8FL1 media. Circle: growth; triangle: viability. Connected points are of 
the same growth passage before being re-suspended into 25% more new media (passage 5 would be of negligible 
residual Sf-900III) 
Although there was no noticeable improvement using 8g/L of FL1, both FL2 and BD had a positive, 
albeit short-lived, effect. This would tend to suggest that there are some compounds in the yeast extract 
that need to be increased in order to improve the growth of Sf-9 cells. In all cases, the cells kept their high 
viability, even though there was no significant growth. Sf-9 cells are known to stay viable in media with a 
sufficient quantity of amino acids and sugars even if the compound required to initiate significant growth 
is absent1. ICP analysis on the media showed a remarkably high variation in the expected and actual trace 
metal supplementation, as shown in Figure 8.13. Of the trace metals supplied in the IPL supplement, only 
Cu was detected in the ALIM media and even this was at a much higher level than expected from the 
supplement. However, when the IPL trace metal concentrate was analyzed (Figure 8.14), all elements 
were detected but at about 20x lower than expected. Even though the IPL supplement is made as a 1000x 
concentrated solution, four elements require <0.030 g when making a 500mL batch, meaning there is a 




the yeast extract would provide more than the supplement for all of the detected elements, Mo cannot 
be detected. Therefore, if this compound is suffering from the same under-supplementation, and it is not 
supplied by the yeast extract, this could explain the severe differences in observed growth.  
 
Figure 8.15: Adaptation of Sf-9 cells in ALIM-8FL2 media. Circle: growth; triangle: viability. Connected points are of 
the same growth passage before being re-suspended into 25% more new media (passage 5 would be of negligible 
residual Sf-900III) 
 
Figure 8.16: Adaptation of Sf-9 cells in ALIM-8BD media. Circle: growth; triangle: viability. Connected points are of 







Figure 8.17: ICP results for each yeast extract, ALIM basal media, and two lots of Sf900III. TMC: Trace metal 
concentrate. Whereas the Sf-900III levels were consistent, ALIM did not have at least the amount expected from the 
supplement, but the yeast extract would more than cover for any deficiencies in it. 
 
Figure 8.18: ICP results for trace metal concentrate (orange) as compared to the expected IPL trace metal 
supplement defined level (green). Significant differences in expected supplementation are obvious, as well as having 




8.2 Cell growth in yeast extract free medium 
Based on the yeast extract and metabolic studies, the supplement in Table 8.3 was used as a CD 
replacement (when added to ALIM, the whole media is referred to as ALIM-CD).  
Table 8.3: Supplement used as a replacement for yeast extract (final concentration when supplemented) 
Trace Metal µM %ALIM 
Co 0.65 309 
Cu 1.5 110 
Fe 3 152 
Mn 1 994 
Mo 0.05 154 
Se 0.5 New 
Zn 5 1704 
Vitamin   
4-Aminobenzoic acid 10 429 
Biotin 3 458 
Cyanocobalamin 0.9 508 
Folic acid 0.9 497 
myo-inositol 20 901 
Pantothenate 10 59567 
Pyridoxone 5 257 
Riboflavin 1 470 
Thiamine 1.5 632 
Vitamin B3 40 3078 
Other   
Adenosine 150 New 
Ascorbate 100 New 
Ethanolamine 50 New 
Ornithine 30 New 
Putrescine 50 New 
Succinate 250 New 
Uridine 40 New 
 
The Fe, Mn, and Zn levels were based off the ICP results and represent a 3, 10, and 17 fold increase 
over the IPL levels, respectively. Se at this level was not seen to be toxic to the cell culture; Mo is unable 
to be detected with this ICP analysis but is increased by about twice that in the IPL supplement (a similar 
increase as the other elements). The vitamins detected in yeast extract were supplemented at similar 
levels achieved from 4g/L; the other vitamins were increased about five-fold over the level in the IPL-41 
supplement. The other components were based off the detected amount in yeast extract. Putrescine, 
ethanolamine and ascorbate were arbitrarily chosen, but significantly less than in other reported defined 
media for insect cells. Ascorbate is added to act as a general antioxidant since suspension cultures are a 




Figure 8.19 presents the adaptation of Sf-9 cells into ALIM-CD. As can be seen, the third passage 
didn’t reach the required density needed to passage the cells and thus no further passages could be 
attempted. However, since passage 2 is about 10% Sf-900III and passage 3 is about 3%, this tends to 
suggest only a small amount of some compound is required to create any meaningful growth.   
 
Figure 8.19: Adaptation of Sf-9 cells in ALIM-CD media. Circle: growth; triangle: viability. Connected points are of the 
same growth passage before being re-suspended into 50% more new media (passage 3 would be of negligible 
residual Sf-900III) 
With all of the studied cell cultures having trouble adapting to their new medium, this could be a 
serious indicator that there are major problems with the lipid solution.  As documented by Gilbert et al.111, 
a lack of lipids had a serious effect on the growth of insect cell lines. While they determined the growth 
was mainly recovered when only Pluronic F-68 was added, it is hard to believe that the lipid solution used 
in this study (which is said to contain 100 mg/mL of it) would not be able to create this same effect at any 
point.  More rigorous investigation is required in order to determine the exact effect and requirements of 




9.0 Overall Conclusions 
This work produced several important results, crucial to both the validation for the use of H-NMR 
spectroscopy in complex solution analysis and to the overall variability that exists in the commercial 
production of yeast extract, which would extend to any other hydrolysate production. 
9.1 Analysis of Yeast Extracts by H-NMR and ICP 
The complex nature of the yeast extract did not impart any additional variability when quantifying solution 
components, as verified through ANOVA and PCA. However, it was shown that PCA is highly sensitive to 
the NMR pre-processing steps and could identify likely spectra with this error.    
While there was no additional variability in the quantification, there was a clear under bias 
imparted by increasing the overall hydrolysate concentration. Increasing the overall concentration did 
allow for the quantification of several compounds which were below the detection limit in more dilute 
samples. This highlights the need for several concentrations of hydrolysate to be analyzed during 
quantification and screening methods. 
There was a high degree of lot and supplier variation. Some compounds (e.g. trehalose, choline 
products, and vitamins) showed a very significant variation between the studied lots. This highlights the 
need for stricter industry control parameters to minimize the variation between products. This variation, 
although seemingly minor based on this analysis, led to significantly different results when the product 
was used in an attempt to grow insect cells. The lot variation was also seen during the trace metal analysis, 
but these results were heavily influenced by the presence of several apparent contaminants, most of 
which are assumed to be a result of the water used to make the hydrolysate and aqua regia solutions. 
Based on the acid digestion of the yeast extract, it was shown the product consisted of about 61% 
amino acids, 11% sugars, and 7% nucleic material. While the vitamins and trace metals only make up 
about 5% of the yeast extract, this still represents a significant increase in their current supplementation 
in media and highlights the need for a considerable increase when transitioning to a chemically defined 
medium.  
9.2 Metabolic Analysis of Sf-9 Cells 
The various yeast extracts produced significantly different results when cell cultures were attempted to 




in-lab media, but it closely mimicked growth obtained in commercial media. This reinforces the fact that 
the crucial component for growth can be found in a variety of products, but not in every lot of the same 
product. This again will require stricter industry control parameters to ensure that lots are more consistent 
with each other. 
 While a chemically defined supplement was devised based on the yeast extract analysis, it was 
unable to sustain any substation growth on its own. However, since growth was still obtained when the 
commercial media was diluted to about 5%, this shows that whatever the crucial component is, only very 
little of it is needed to initiate growth.  The replacement contained several novel compounds without a 





10.0 Future Work and Recommendations 
This analysis provides several interesting opportunities for further research. 
10.1 Chemically Defined Medium Replacement 
Most of the compounds used in this supplement have never been studied before and therefore it is 
unknown how close these compounds are to their individual, or any combined, toxicity limit. However, 
since the cells remained viable during the metabolic study, none of these compounds are currently at 
this threshold and thus increasing their concentrations may boost them into the necessary range. Since 
the vitamins and trace metals have already been increase substantially, the next step would be to see if 
increasing the novel components’ concentration will have any benefits.  
10.2 Lot and Supplier Variability of Yeast Extract 
It would be beneficial to analyze several more lots and suppliers of yeast extract to have a more complete 
understanding of the possible variations that can occur between suppliers and their lots. This can be 
paired with more metabolic analysis to see which lots can induce growth in insect cells. These lots can 
then be subjected to more rigorous analysis techniques (e.g. GC-MS, fractionation), to see if any more 
similarities can be distinguished and allow for more insights into a defined supplement.  
10.3 ICP Analysis 
Due to the considerable amount of contaminants detected during the trace metal analysis, it is believed 
that the source of the water used for both the hydrolysate and aqua regia solutions are critical in order 
to eliminate all sources of error. Further, the current machine can be calibrated to detect selenium, a 
crucial element expected to play a significant metabolic role in insect cultures.  
10.4 Bioactivity of Insect Culture Supernatant 
To more fully understand any possible enzymatic activity which occurs in the supernatant separate from 
metabolic processes, disaccharides and yeast extract can be digested in supernatants of various ages to 
see which reactions occur. This could allow for a greater understanding of the metabolic needs of the 
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Appendix A – Matlab Code – Curve Fitting 
Coupled Glucose ODE Model 
function ODE_nonlinfit 
  
%grab data from relevant Excel Spreadsheet location 
T = [0;30;60;90;120;180;240;360;720]; 
Yavg = xlsread('Triplicate','Biological Triplicate Others','B24:J24')'; 
Stdv = xlsread('Triplicate','Biological Triplicate Others','L24:T24')'; 
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alpha = 1 
opts = statset('nlinfit'); 
opts.RobustWgtFun = 'bisquare'; 
B0=[0.01 0.0001]’; 
  
%ODE Parameter Solving 
[beta,R,J,CovB,MSE,ErrorModelInfo] = nlinfit(T,Yavg,@odemodel,B0,opts); 
  
%Optimum Parameter Solution 




%R2 and CI calculations 
avg = mean(Yavg).*ones(9,1); 
SST = sum((Yavg-avg).^2); 
SSE = sum(R.^2); 
CI=nlparci(beta,R,'jacobian',J); 
Beta_CI = [CI(:,1) beta CI(:,2)] 
Beta_Range_Percent = (beta - CI(:,1))./beta 
R2 = 1-SSE/SST 
  
    function C = odemodel(B,t)     
        function dC = ode(t,C) 
            
           dC = zeros(2,1);                  %Coupled Glucose Kinetics 
           dC(1) = -B(1)*(C(1))^alpha; 
           dC(2) = B(1)*C(1)^alpha-B(2); 
        end 
  
        [t,C] = ode45(@ode,T,[Yavg(1)]); 
        C=C2(:,2); 





    function dC=ode2(t,C,beta) 
                 
             dC = zeros(2,1); 
             dC(1) = -beta(1)*C(1); 
             dC(2) = beta(1)*C(1)-beta(2); 
    end 
  end 
 







% Grab data from relevant Excel Spreadsheet location 
Yavg = xlsread('Triplicate-Reprofile July3-17 ML','Average', 'B33:J33')';% 
[w%] 
Stdv = xlsread('Triplicate-Reprofile July3-17 ML','Average', 'L33:T33')';% 
[w%] 
[~,tit]=xlsread('Triplicate-Reprofile July3-17 ML','Average','A33'); 
%compound name 
T = [0;30;60;90;120;180;240;360;720];% [min] experimental times 
%Yavg = [Yavg(1);Yavg(4:9)]; 
%Stdv= [Stdv(1);Stdv(4:9)]; 
Tspan = [0:5:720];% [min] modelled times 
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% Parameter setting 
opts = statset('nlinfit'); 
opts.RobustWgtFun = 'bisquare'; 
  
% Initial Parameter estimates 
%B0 = [max(Yavg)-Yavg(1),0.01]'; % Increasing kinetics [Co, h] 
%B0 = [max(Yavg)-Yavg(1),0.01,0.0001]'; % Combined kinetics [Co, h, d] 
B0 = [Yavg(1), 0.01]; % Decreasing kinetics [Bo, d] 
%B0=0; 
  







% Optimum Parameter Solution 
%Yest = beta(1)*(1-exp(-beta(2)*Tspan)) + Yavg(1); % Increasing kinetics 
%Yest = beta(1)*beta(2)/(beta(2)-beta(3))*(exp(-beta(3).*Tspan)-exp(-
beta(2).*Tspan)) + Yavg(1)*exp(-beta(3).*Tspan); % Combined kinetics 
Yest=beta(1)*exp(-beta(2)*Tspan); % Decreasing kinetics 
%Yest=Yavg(1)+beta(1)*Tspan; 
  





% R2 and CI calculations 
avg = mean(Yavg(1:9)).*ones(9,1); 
SST = sum((Yavg(1:9)-avg).^2); 
SSE = sum(R.^2); 




Beta_Range_Percent = (beta' - CI(:,1))./beta' 
  
    function C = model(B,t)     
        %C=B(1)*(1-exp(-B(2)*t)) + Yavg(1); % Increasing kinetics 
        %C=B(1)*B(2)/(B(2)-B(3))*(exp(-B(3)*t)-exp(-B(2)*t)) + Yavg(1)*exp(-
B(3)*t); % Combined kinetics 
        C=B(1)*exp(-B(2)*t); % Decreasing kinetics [Bo, d] 
        %C=Yavg(1)+B(1)*t; 
    end 
  




Appendix B – ALIM Media Formulation 
Amino Acids g/L Sugars g/L Trace Metals2 µg/L 
DL-Serine 0.74 Glucose 3.90 (NH4)Mo7O24·4H2O 40 
Glycine 0.20   CoCl2·6H2O 50 
L-Arginine 1.22 Salts  CuCl2·2H2O 200 
L-Asparagine 1.30 CaCl2 0.50 FeSO4·7H2O 550 
L-Aspartic acid 1.30 KCl 1.20 MnSO4·H2O 17 
L-Cystine1 0.20 MgSO4 7H2O 1.88 ZnCl2 40 
L-Glutamic acid 1.50 NaCl 2.72   
L-Glutamine 2.19 NaH2PO4 1.01 Vitamins2  
L-Histidine 0.20 NaHCO3 0.35 4-Aminobenzoic acid 320 
L-Isoleucine 0.75  
 Biotin 160 
L-Leucine 0.66  mg/L Calcium pantothenate 8 
L-Lysine HCl 0.70 Choline chloride 70 Cyanocobalamin 240 
L-Methionine 1.00   Folic acid 80 
L-Phenylalanine 1.00   myo-Inositol 400 
L-Proline 0.50   Niacin 160 
L-Threonine 0.60   Pyridoxine HCl 400 
L-Tryptophan 0.41   Riboflavin 80 
L-Tyrosine1 0.50   Thiamine 80 
L-Valine 0.50     
      
      
 
Notes: 
1: Made as a 75x solution in 1M HCl before adding 13.3mL to media 




Appendix C – Extended Figures and Tables 
C1 Scanning Variance of FL3 Yeast Extract – Complete Results 
Yellow – Cov > 5% Red – CoV > 10% 
 A B C Overall 
 Avg CoV Avg CoV Avg CoV Avg CoV 
2-Hydroxyisobutyrate 0.01% 8.18% 0.01% 6.24% 0.01% 10.50% 0.01% 8.70% 
3-Hydroxyisovalerate 0.06% 3.35% 0.06% 1.97% 0.06% 5.12% 0.06% 4.51% 
4-Aminobutyrate 0.10% 1.00% 0.10% 4.25% 0.10% 3.67% 0.10% 3.36% 
Acetate 0.41% 2.59% 0.42% 4.59% 0.41% 6.57% 0.41% 4.44% 
Adenine 0.02% 14.15% 0.02% 4.76% 0.02% 9.58% 0.02% 10.18% 
Adenosine 1.34% 3.58% 1.36% 0.55% 1.35% 1.72% 1.35% 2.14% 
Alanine 3.41% 2.23% 3.45% 3.84% 3.30% 2.15% 3.39% 3.25% 
Arginine 1.74% 3.50% 1.74% 1.36% 1.70% 0.95% 1.72% 2.27% 
Asparagine 1.72% 1.42% 1.68% 2.00% 1.72% 2.66% 1.71% 2.17% 
Aspartate 2.20% 3.00% 2.20% 2.82% 2.20% 3.56% 2.20% 2.84% 
Betaine 1.21% 3.73% 1.22% 2.12% 1.21% 1.10% 1.22% 2.33% 
Butyrate 0.09% 5.02% 0.09% 7.04% 0.09% 3.16% 0.09% 6.23% 
Choline 0.03% 4.83% 0.02% 5.73% 0.03% 1.68% 0.03% 4.20% 
Cystine 0.07% 24.13% 0.07% 22.39% 0.05% 14.66% 0.06% 21.90% 
Cytidine 0.05% 12.46% 0.05% 8.55% 0.04% 24.73% 0.05% 15.21% 
Formate 0.03% 5.21% 0.03% 5.99% 0.03% 1.90% 0.03% 5.96% 
Glucose 0.55% 0.60% 0.55% 1.76% 0.59% 3.17% 0.56% 3.65% 
Glutamate 7.17% 3.05% 7.15% 2.97% 7.03% 3.67% 7.12% 3.07% 
Glutamine 0.36% 1.71% 0.37% 6.47% 0.37% 7.65% 0.37% 5.32% 
Glycerol 0.08% 4.43% 0.08% 10.32% 0.08% 7.59% 0.08% 7.51% 
Glycine 1.51% 2.04% 1.44% 3.12% 1.49% 3.78% 1.48% 3.41% 
Guanosine 0.14% 2.25% 0.14% 2.70% 0.14% 4.56% 0.14% 3.02% 
Histidine 0.73% 2.58% 0.72% 1.67% 0.72% 4.49% 0.73% 2.94% 
Hypoxanthine 0.04% 7.24% 0.04% 8.10% 0.04% 4.39% 0.04% 6.76% 
Inosine 0.02% 15.75% 0.02% 20.72% 0.02% 13.33% 0.02% 16.13% 
Isobutyrate 0.16% 1.89% 0.16% 0.90% 0.15% 4.26% 0.16% 3.05% 
Isoleucine 2.67% 2.88% 2.60% 3.56% 2.66% 2.72% 2.64% 3.02% 
Lactate 0.07% 14.01% 0.05% 14.79% 0.06% 5.97% 0.06% 15.82% 
Leucine 3.77% 1.59% 3.81% 2.70% 3.72% 3.28% 3.77% 2.60% 
Lysine 1.91% 1.87% 1.85% 2.44% 1.96% 1.61% 1.91% 3.15% 
Methionine 1.04% 2.04% 1.03% 2.64% 1.01% 1.62% 1.02% 2.27% 
Niacinamide 0.06% 7.37% 0.06% 4.28% 0.06% 6.10% 0.06% 6.20% 
Nicotinate 0.05% 9.50% 0.05% 8.00% 0.05% 4.78% 0.05% 7.31% 
Ornithine 0.18% 7.18% 0.18% 2.22% 0.18% 4.17% 0.18% 4.55% 
Pantothenate 0.11% 2.84% 0.12% 14.02% 0.12% 9.41% 0.12% 9.58% 
Phenylalanine 2.41% 0.63% 2.47% 3.61% 2.42% 2.43% 2.43% 2.58% 
Proline 0.96% 1.97% 0.93% 2.44% 0.96% 2.42% 0.95% 2.81% 
Pyroglutamate 1.52% 3.26% 1.53% 5.19% 1.52% 3.20% 1.52% 3.62% 
Sarcosine 0.01% 14.56% 0.00% 13.77% 0.00% 7.82% 0.01% 13.14% 
Serine 2.22% 1.03% 2.12% 5.37% 2.21% 4.05% 2.18% 4.06% 
Succinate 0.60% 1.99% 0.60% 2.50% 0.60% 2.95% 0.60% 2.33% 
Threonine 2.11% 3.25% 2.10% 2.38% 2.06% 0.86% 2.09% 2.40% 




Tryptophan 0.70% 1.05% 0.70% 2.15% 0.69% 2.69% 0.70% 2.09% 
Tyrosine 0.67% 0.73% 0.67% 4.27% 0.65% 3.11% 0.66% 3.12% 
Uracil 0.16% 2.60% 0.16% 5.35% 0.16% 1.76% 0.16% 3.43% 
Uridine 0.35% 6.19% 0.35% 4.83% 0.36% 8.16% 0.35% 6.16% 
Valine 3.01% 3.28% 2.95% 5.52% 2.94% 1.49% 2.96% 3.63% 
myo-Inositol 0.12% 15.62% 0.12% 16.92% 0.13% 9.43% 0.13% 14.08% 
a-Glycerophosphocholine 0.30% 2.78% 0.30% 2.90% 0.31% 2.95% 0.30% 3.03% 
 
